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Abstract 
Piscirickettsia salmonis (P. salmonis) is a small gram-negative intracellular pathogenic 
bacterium found in farmed and wild salmonid and other marine fish. P. salmonis replicates 
within membrane-bound cytoplasmic vacuoles in cells of infected fish, leading to a systemic 
infection, known as salmonid rickettsial septicaemia (SRS), or piscirickettsiosis. 
Piscirickettsiosis is characterized by necrosis, pale gills, swollen kidney, and enlarged spleen, 
leading to high rates of mortality in infected fish populations. High rates of mortality due to P. 
salmonis infections have led to severe economic losses for the salmonid aquaculture industry, 
causing a loss of at least 100 million US dollars in Chile alone, and even more on a global 
basis. Due to the effects of piscirickettsiosis on the aquaculture, several studies have been 
focusing on vaccination and treatment. However, there have been few positive results due to 
lack of cultivation methods for P. salmonis, only recently it was grown independently of 
cultured cell lines.  
In this thesis, improved procedures for growing P. salmonis in the laboratory were established 
which is a significant leap forward for research on this bacterium. Optimal medium and 
growth conditions to culture P. salmonis were obtained. Growth rate and CFU/ml could then 
be measured. When growth measurements were performed, it was discovered that P. salmonis 
grow better in the dark. Therefore, growth during stress conditions at different alterations in 
exposure to light was investigated. Several different approaches to make GFP-labeled bacteria 
were unsuccessful, and it was shown that P. salmonis have naturally occurring plasmids. 
Antibiotic susceptibility test was performed and P. salmonis strains were found to be sensitive 
to the majority of antibiotics used in vitro. Electron microscopy studies identified P. salmonis 
as pleomorphic coccus bacterium of 500-800 nm in size with the secretion of outer membrane 
vesicles. The outer membrane vesicles were further characterized by both scanning and 
transmission electron microscopy and the protein content analysis was performed by SDS-
PAGE and Western blotting. Additionally, P. salmonis pathogenesis was studied by using the 
CHSE-214 cell line where the infection rate was approximately 10 % higher in the dark. 
Additionally, a P. salmonis-zebrafish embryo infection model was established. The bacteria 
were confirmed to be intracellular by whole-mount immunohistochemistry and by live 
imaging using transgenic zebrafish lines with fluorescently labeled leukocytes. This thesis 
lays a solid foundation for further research on P. salmonis and subsequent treatment against 
piscirickettsiosis.  
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Sammendrag 
Piscirickettsia salmonis (P. salmonis) er en liten gram-negativ intracellulær patogen bakterie som har 
blitt funnet i oppdrett- og frittlevende arter av laksefamilien, men også i andre havfisk. P. salmonis 
kan formere seg inni cytoplasmiske vakuoler i celler hos infiserte fisk. Dette vil føre til en systemisk 
sykdom kjent som salmonid rikettsial septikemi (SRS), eller piscirickettsiose. Vanlige symptomer er 
bleke gjeller, forstørret milt, svulne nyrer og leveren er ofte gjennomsatt av store, lyse, nekrotiske 
forandringer (lokal vevsdød). Dette kan føre til høy dødelighet i infiserte fiskepopulasjoner. 
Akvakulturindustrien som driver med oppdrett av laksefisker opplever store økonomiske tap som følge 
av P. salmonis infeksjon. Chile har et årlig økonomisk tap på minst 100 millioner amerikanske dollar, 
og dette tallet blir enda større på en global basis. Disse store økonomiske tapene forårsaket av 
piscirickettsiose i akvakulturen har ført til studier av vaksinering og behandling. Dette har gitt få 
positive resultater, mest sannsynlig på grunn av manglende kultiverings metoder for P. salmonis. Det 
ble lenge antatt at P. salmonis kun kunne vokse i fiskecellelinjer, men nylig ble det for første gang 
påvist at den kan bli kultivert uavhengig av cellelinjer.  
I denne oppgaven ble det etablert forbedrede prosedyrer for å dyrke P. salmonis på laboratoriet. Dette 
er et stort framskritt som vil gjøre forskningen på denne bakterien enklere. Det optimale mediet og 
forholdene for dyrkning ble funnet, og vekst og CFU/ml ble målt. Under vekst-målingene ble det 
observert at P. salmonis vokste bedre i mørket enn i lyset. Derfor ble bakterien utsatt for stress i tillegg 
til lys og mørke forhold. Det ble testet flere metoder for å lage GFP-merkede P. salmonis mutanter, 
uten noe suksess. I denne oppgaven ble det også vist at P. salmonis har naturlige plasmider. I tillegg 
ble antibiotika sensitivitet testet som viste at bakteriene var veldig følsomme for ulike typer antibiotika 
in vitro. Elektron mikroskop ble videre brukt for å identifisere størrelsen og formen på bakteriene som 
viste at de var runde med en størrelse på 500-800 nm. Ved å bruke skanning og transmisjon 
elektronmikroskop ble det observert at P. salmonis sekrerer yttermembranvesikler. Protein innholdet i 
disse vesiklene ble videre analysert ved SDS-PAGE og Western blotting. P. salmonis patogenese ble 
også studert ved å benytte CHSE-214 cellelinjen der infeksjonen viste seg å være 10 % høyere i 
mørke, og en P. salmonis-sebrafisk embryo infeksjonsmodellen ble etablert. Bakterien ble bekreftet å 
være intracellulær med en immunhistokjemisk metode og ved å bruke transgene sebrafisklinjer med 
fluoriserende leukocytter. Resultatene i denne oppgaven gir et godt fundament for forskning på P. 
salmonis og for videre studier nødvendig for å finne en effektiv behandling imot piscirickettsiose.       
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1 Introduction 
1.1 Aquaculture 
According to the Fisheries and Aquaculture department of Food and Agriculture Organization 
of the United Nations (FAO), aquaculture is the farming of aquatic organisms including 
molluscs, crustaceans, aquatic plants and fish. Farming of fish is the most common form of 
aquaculture. The global aquaculture production of farmed fish in 2012 was approximately 66 
million tonnes, accounting for around 50 % of the world‘s fish food supply (Bostock et al., 
2010). Asia dominates this production, with China as the largest producer. However, as a 
market for fish and seafood; Europe and North America are not far behind, and the  
production is still increasing (Bostock et al., 2010). As the human population continues to 
expand its reliance on farmed fish production as an important source of protein will also 
increase (Naylor et al., 2000). Thus the production of farmed fish will need to become even 
higher during the next years. According to the latest estimates (Food and Agriculture 
Organization of the United Nations, 2014a), fish farms would have to produce 50 million 
additional tonnes of food fish by 2030 to meet the increasing consumption. In addition, there 
is a common opinion that this increased production will relieve pressure on ocean fisheries, 
but in fact the opposite is true for some types of aquaculture (Naylor et al., 2000). Farming 
carnivorous species like salmon and shrimp requires large inputs of wild fish for feed. This 
has led to the use of industrial fishing to support aquaculture. For instance, from 1985 to 
1995, the world‘s shrimp farmers used approximately 36 million tons of wild fish to produce 
just 7.2 million tons of shrimp (Frankic and Hershner, 2003). The wild fish that often are used 
as feed are anchovies, herring, sardines and mackerel, which also can be used as food for 
human consumption. From 1992 to 2003 total fishmeal and fish oil used in salmon production 
have increased from 261 to 982 thousand tonnes (Tacon, 2005). Aquaculture is a possible 
solution for the world‘s need for food, however it is also a contributing factor to the collapse 
of fisheries stocks worldwide (Naylor et al., 2000).  
Several countries including Norway have made large investments in the aquaculture industry, 
mainly due to the fact that it is a profitable business and Norway`s long coastline surrounded 
by cold, fresh seawaters provides excellent conditions for aquaculture industry. Norway has a 
long history in the fish industry and the aquaculture began in the early 1970s, and has 
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expanded ever since. Today, fish is Norway`s third most valuable export product, with a total 
aquaculture production of more than 1.3 million tonnes in 2012. The primary farmed fish 
species are the salmonid fish, such as Atlantic salmon Salmo salar and Rainbow trout 
Oncorhynchus mykiss (Food and Agriculture Organization of the United Nations, 2014b) with 
the sale of salmon in 2012 came to a first-hand value of 30 billion Norwegian krones 
according to The Central Bureau of Statistics (Fig. 1.1.1) (Statistics Norway, 2014).    
 
Fig. 1.1.1: Amount of salmon produced in tonnes from year 1997 to 2012 is indicated by the green bars. The 
purple line shows value in million NOK (Statistics Norway).     
An important factor allowing further increase in fish production is the need to better control 
the many viral and bacterial diseases that cause significant losses in aquaculture such as the 
parasitic sea lice. Sea lice are the most damaging parasite to the salmonid farming industry 
(Costello, 2009). Exposure to viral and bacterial pathogens is impossible to avoid for species 
reared in nets in open aquatic environment (Sommerset et al., 2005). The annual economic 
loss associated with fish pathogens between 1990 and 1992 in China was estimated to more 
than 120 million US dollars (Pridgeon and Klesius, 2013). The same is the case for the 
Chilean salmon aquaculture industry, where loss due to diseases caused by fish pathogens 
exceeds 100 million US dollars annually (Bustos et al., 2006). The bacterial diseases alone 
affecting aquaculture production collectively lead to global losses of hundreds of millions to 
billions of dollars annually (Pridgeon and Klesius, 2013). Many viruses e.g infectious salmon 
anemia virus cause serious diseases in farmed Atlantic salmon (Salmo salar) (Crane and 
Hyatt, 2011). Also several bacterial species, such as Aeromonas, Piscirickettsia, Vibrio and 
Moritella (Toranzo et al., 2005) are pathogenic for fish. 
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Several antibiotics are used for the treatment of fish bacterial diseases (Samuelsen et al., 
2006). However, treatment with antibiotics is limited by several practical constraints. 
Antibiotics can be administered by injections, bath treatment or orally. Injections are 
expensive and stressful for the fish, and in bath treatments the salt content in seawater can 
reduce the ability of adult fish to absorb the antibiotics. Oral administration with food pellets 
is the preferred method for adult fish, however this treatment is intended to control the level 
of infection in the group rather than infection in individual fish (Samuelsen et al., 2006). This 
is due to loss of appetite of infected fish and therefore oral treatment will mainly be delivered 
to uninfected fish. In addition, overuse of antibiotics in the aquaculture can lead to antibiotic 
resistant pathogens. Therefore, the key point in the successful fish production is the 
development of vaccines. At present, there are many vaccines on the market against some of 
the most serious bacterial diseases that cause major problems for the aquaculture. For 
example injectable vaccines were developed in 1990s against furunculosis caused by the 
bacterium Aeromonas salmonicida (Sommerset et al., 2005). After a few years of testing with 
different vaccine adjuvants and antigen combinations, it became evident that all antigens in 
one oil-adjuvanted vaccine was the product of choice, and the excellent efficacy of these 
vaccines reduced the use of antibiotics (Sommerset et al., 2005). There are several vaccines 
developed against bacterial infections such as cold-water vibriosis or “Hitra disease” caused 
by Vibrio salmonicida (Lillehaug, 1990). However, both vaccines and antibiotics have limited 
effect if the pathogen has an intracellular nature, as can be exemplified by Piscirickettsia 
salmonis (P. salmonis). P. salmonis infection is one of the most serious problems in the 
Chilean aquaculture industry (Sommerset et al., 2005), which also affects Norwegian fish 
production to some extent. After the outbreak of piscirickettsiosis in Norway in 1987 (Olsen 
et al., 1997), only sporadic outbreaks have been recorded.  
P. salmonis has not been extensively studied, which hampers the development of therapeutic 
strategies. In 1989, approximately 1.5 million Coho salmon (Oncorhynchus kisutch) died 
from the infection in Chile, this caused an economic loss of 10 million US dollars (Cvitanich 
et al., 1991). Since the original outbreak in 1989, the number and severity of outbreaks have 
since increased (Rozas and Enríquez, 2013). The disease is a threat to the salmonid industry, 
not only for marine net pens, but also freshwater hatcheries (Gaggero et al., 1995). According 
to the National Service of Fisheries and Aquaculture, there were 664 fish diagnostics positive 
to piscirickettsiosis in the first nine months of 2012 (Pèrez, 2012). In addition, each new 
outbreak shows a different character with increased bacterial virulence; thereby introducing 
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even more challenges with regards to diagnosis, prevention, treatment and control (Rozas and 
Enríquez, 2013).  
1.2 Piscirickettsia salmonis 
1.2.1 Classification and properties 
The bacterium P. salmonis was initially grouped in the family Rickettsiaceae and was referred 
to as rickettsia-like, because of the similarities with other bacteria in the family (Cvitanich et 
al., 1991, Fryer et al., 1990). Subsequently, the bacterium was classified in a new family 
Piscirickettsiaceae in the phylum Proteobacteria, class Gammaproteobacteria, order 
Thiotrichales (Fryer and Hedrick, 2003) and assigned to a new genus and species 
Piscirickettsia salmonis (Fryer et al., 1992). This was due to molecular phylogenetic methods 
based on sequencing of the 16S rRNA gene. The sequence of the 16S rRNA gene confirmed 
the association of P. salmonis with the Gammaproteobacteria, instead of the Rickettsia, that 
are grouped within the Alphaproteobacteria (Fryer and Hedrick, 2003).  
P. salmonis is a small, fastidious, gram-negative intracellular pathogenic bacterium found in 
farmed and wild salmon and other marine fish. The bacterium is generally described as non-
motile, non-encapsulated, aerobic, pleomorphic, predominately coccoid with an approximate 
diameter of 0.5-1.5 µm, but can also be found in pairs or ring-shaped structures (Fryer et al., 
1990, Fryer et al., 1992). P. salmonis replicates by binary fission within membrane-bound 
cytoplasmic vacuoles in cells of infected fish or fish cell lines, for instance Chinook salmon 
embryo-214 cell line (CHSE-214) (Fryer et al., 1990). Previously, P. salmonis were 
considered unable to grow outside a host cell (Fryer et al., 1990), but recently several 
publications describe media in which the bacterium is able to grow, both on agar medium and 
in liquid culture (Mikalsen et al., 2008, Mauel et al., 2008, Gómez et al., 2009, Yanez et al., 
2013, Henriquez et al., 2013). Mikalsen et al. (2008) described an agar culture medium based 
on cysteine heart agar supplemented with 5 % ovine blood (CHAB), and after 6 days of 
incubation P. salmonis colonies had reached 1 mm in diameter. On the other hand, Yanez et 
al. (2013) described two novel blood-free solid media; tryptone soy with ferric nitrate 
(Austral-TSFe) agar and tryptone soy with heamoglobin (Austral-TSHem) agar. The growth 
of P. salmonis was approximately 8-10 days on the Austral-TSHem and Austral-TSFe plates, 
which was a significant leap forward, as blood-free plates is preferred, since blood can be a 
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cause of contamination or difficult to obtain. Henriquez et al. (2013) has also demonstrated a 
blood-free bacteriological liquid medium with yeast extract and peptone. It was reported that 
P. salmonis could grow to an OD600 value of 1.7 in only 37.5 hours. The ability to grow P. 
salmonis in laboratory conditions allows one to study its growth and pathogenesis. This may 
lead to a possible vaccine development, providing a treatment plan for the disease caused by 
P. salmonis, known as salmonid rickettsial septicaemia (SRS), or piscirickettsiosis (Mauel et 
al., 2008).    
1.2.2  Piscirickettsiosis and current state of treatment strategy 
In the late 1980s piscirickettsiosis started to spread among net pen-reared salmonid stocks in 
the aquaculture industry in Chile. It appeared that the disease began after fish were introduced 
into the seawater net pens (Bravo and Campos, 1989). Intensive efforts were made to classify 
the organism responsible for the disease, and eventually the bacterium was classified as 
Piscirickettsia salmonis and the disease was then named piscirickettsiosis, or SRS (Fryer et 
al., 1992). Coho salmon (Oncorhynchus kisutch) was the main species affected by the disease 
with a mortality rate of 30 - 90 % in 1989 (Bravo and Campos, 1989). The disease was, 
however, not restricted to Chile and in later years piscirickettsiosis has also been observed in 
Ireland (Rodger and Drinan, 1993), Norway (Olsen et al., 1997) and Canada (Cusack et al., 
2002), where it affected not only Coho salmon, but also other farmed and wild salmonid and 
marine fish (Mikalsen et al., 2008). Reports of P. salmonis infection in marine fish include 
European seabass, Dicentrarchus labrax (McCarthy et al., 2005) and white seabass 
Atractoscion nobilis (Arkush et al., 2005). Numerous anti-microbial agents have also been 
used to control the disease without any reasonable success.  
The route of disease transmission is not completely understood, but it has, however, been 
demonstrated that P. salmonis‘s main entry site is through the skin and gills (Smith et al., 
1999). In the study performed by Smith et al. (1999), Rainbow trout were infected with P. 
salmonis at 6 different entry sites to study the routes of natural infection. P. salmonis was 
reported to penetrate the skin in the absence of injury and without the assistance of another 
vector. In addition, P. salmonis could reach the gill capillaries and disseminate through the 
body in a relative short time. However, oral exposure is not an important route of 
transmission, and the theory is that the low pH and digestive enzymes in the stomach 
inactivates the bacterium. Similar studies has been performed in Atlantic salmon, were they 
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showed that gills might be important portals of entry for natural transmission of P. salmonis 
(Almendras et al., 1997).      
No reservoirs or vectors are known, but there are many parasitic crustaceans in the marine 
environment that could serve as vectors for P. salmonis (Fryer et al., 1990). P. salmonis is 
obviously protected from desiccation in aquatic environments, and therefore it is possible that 
no vector is required (Fryer et al., 1990). However, it has been shown that P. salmonis can 
replicate in insect- and frog-derived cell lines (Birkbeck et al., 2004a), and a parasitic isopod 
associated with farmed salmon in Chile, was identified as a host for P. salmonis. 
Subsequently, a reservoir in marine finfish species has been suspected, but not proven (Rozas 
and Enríquez, 2013). In addition, P. salmonis are not only restricted to salmonid hosts, as the 
disease has been observed also in non-salmonids (McCarthy et al., 2005). Therefore, it is 
some evidence that a vector and a reservoir may exist, but further studies are needed.          
The experimental work on whether vertical transmission occurs is in progress, yet little is 
known. P. salmonis have been described in the ovaries, testicles and coelomic fluid of 
infected salmon (Cvitanich et al., 1991). Larenas et al. (2003), observed that fish eggs were 
infected from an early development phase in ovary tissue and that the tissue could produce 
gametes that were viable carriers of the bacteria (Larenas et al., 2003). Horizontal, or fish-to-
fish dependent transmission of P. salmonis has been demonstrated in both fresh and salt 
water, and it is enhanced by direct contact among fish (Almendras et al., 1997). Subsequently, 
natural horizontal transmission in seawater was demonstrated in stocks of salmon. After P. 
salmonis introduction into the fish bath, mortality occurred within 2 weeks (Bravo, 1994). 
The same was observed by Cvitanich et al. (1991); horizontal transmission can occur in Coho 
salmon held in seawater or fresh water without parasite vectors (Cvitanich et al., 1991). 
Another hypothesis is that P. salmonis can be released through fish feces, and survive to 
infect other fish (Cvitanich et al., 1991). In vitro experiments examining extracellular survival 
of P. salmonis from Coho salmon showed no detection of infectious P. salmonis after 
exposure to freshwater, but P. salmonis was detected in salt water (Lannan and Fryer, 1994). 
Due to this finding, horizontal transmission in marine waters is very probable. However the 
situation is not the same in fresh water where it seems like the bacterium has to be protected 
within host cells or a vector if horizontal transmission is to occur (Lannan and Fryer, 1994). 
P. salmonis can survive for up to 14 days in seawater (Lannan and Fryer, 1994), and the long 
survival of P. salmonis in seawater, is possibly due to the ability to create a biofilm and thus 
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withstand stress conditions (Marshall et al., 2012). Biofilms are a collection of microbial cells 
that are densely packed, can adhere to solid surfaces and surround themselves with secreted 
polymers (Costerton et al., 1999). Environmental conditions can trigger the transition from 
free living to a life on a surface, or in cell aggregates (Marshall et al., 2012). Many pathogenic 
bacteria produce biofilms as an important survival strategy and biofilm formation may 
promote survival of P. salmonis in seawater, and thereby allow for the infection of fish.  
The fish that are affected by P. salmonis often exhibit symptoms, though the clinical signs are 
variable. Severely affected fish can appear darker in color, with pale gills, are lethargic, loss 
of appetite, show skin lesions or ulcers and have abnormal swimming behavior, such as 
swimming near the surface or edges of the cages. In addition, most affected fish have internal 
symptoms where several organs and tissue are involved, like swollen kidney, liver and spleen 
(Cvitanich et al., 1991, Fryer and Hedrick, 2003) (Fig. 1.2.1). 
 
Fig. 1.2.1: Symptoms associated with piscirickettsiosis in salmon species. A: Skin ulcers at different areas of the 
body. B: Big skin ulcer. C: Pale liver (Rozas and Enríquez, 2013).     
Multifocal necrosis can also happen in the more acute phase of piscirickettsiosis, and it is 
usually followed by granulomatous inflammation. A granuloma is a collection of immune 
cells, such as macrophages, and it may occur in many diseases. Granulomas are usually 
formed as a result of hypersensitivity responses or of the persistence of a non-degradable 
product (Mukhopadhyay et al., 2012). Macrophages are phagocytic cells, and after ingestion, 
the pathogen will be located in a membrane-bound vacuole (phagosome). However, the 
trafficking of this vacuole and the bacterial survival strategies vary considerably (Garcia-del 
Portillo and Finlay, 1995). To succeed as an infectious pathogen, the pathogen must have a 
survival strategy. It has to colonize a host, reach an niche, avoid host defense, replicate, exit 
from the host and be transmitted to a new host (Rojas et al., 2013). The bacteria without an 
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intracellular survival strategy are digested, due to phagosome fusion with the lysosomal 
compartment. This compartment contains hydrolytic enzymes and a low pH, that can facilitate 
killing of the pathogens, and in some cases also the presentations of antigens to the immune 
system (Ernst et al., 1999). There are several different strategies to avoid the hostile 
environment of the macrophage phagosome (Fig. 1.2.2). The pathogen can reside in a 
phagosome that blocks the fusion with lysosomes, as seen in Legionella and Mycobacterium 
(Ernst et al., 1999). They can escape the phagosome after lysing the phagosomal membrane 
and resides freely in the host cell cytoplasm, as seen in Listeria and Shigella infection (Ernst 
et al., 1999). Salmonella species have another strategy; they have adapted to resist the 
antimicrobial activity of the fused phagolysosme (Ernst et al., 1999). However, which escape 
strategy is used by the pathogen P. salmonis is still unknown.   
 
Fig. 1.2.2: Trafficking within the endocytic pathway and the different intracellular pathogens have evolved 
various ways of avoiding being degraded within the cell (Santic et al., 2006).    
In P. salmonis infection, macrophages can be found within areas of necrosis, where they 
harbor intracellular aggregates of P. salmonis. According to Rojas et al. (2009) this obligate 
intracellular pathogen can survive within phagocytic cells. The bacterium is able to survive 
and propagate inside salmonid macrophages and monocyte-like cells without inducing 
cytopathic effect (CPE) (Rojas et al., 2009, McCarthy et al., 2008). This is a potential survival 
strategy, and the combination of intracellular growth and regulation of macrophage cell death 
could be the basis for P. salmonis`s pathogenesis. Subsequently, it has been shown that P. 
salmonis can induce apoptosis (programmed cell death) in macrophages and monocyte-like 
cells (Rojas et al., 2010). The mechanism behind this process has not been described, but it 
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could be that P.salmonis produces toxins that activate macrophage apoptosis, but no such 
toxins have been identified yet (Rojas et al., 2010). The virulence factors of this pathogen are 
poorly known though it has been recently found that P. salmonis secretes extracellular 
products, and the hypothesis is that some of these compounds may have a cytotoxic effect in 
vitro and probably mediate some tissue damage in vivo (Rojas et al., 2013). Recently, the first 
draft genome sequence of P. salmonis LF-89 was published (Eppinger et al., 2013) which can 
be important for revealing P. salmonis virulence factors. The 3,388,517-Mbp draft genome 
sequence had a G+C content of 39.2%. Eppinger et al. (2013) found the presence of type ӀV 
pilus genes and bacteriophage genes in the genome. Type ӀV secretion genes were found in 
large clusters, which may be critical for intracellular survival. Finally, flagellar and 
chemotaxis genes were present in the genome, which is unexpected due to the fact that the 
bacterium is characterized as non-motile. The flagellar gene organization suggests that P. 
salmonis synthesizes a single polar flagellum (Eppinger et al., 2013). Further mapping of the 
P. salmonis genome may provide new information in regards to this pathogen, which still is a 
major problem in aquaculture. 
Piscirickettsiosis has led to severe economic losses for the Chilean salmon aquaculture 
industry, causing a loss of at least 100 million US dollars in Chile alone and even more on 
global basis. Today, piscirickettsiosis is still a big threat to brackish and seawater aquaculture 
(Bustos et al., 2006). A reason for this threat is the difficulties in using effective antibiotics 
and developing good vaccines, due to the bacterium‘s intracellular nature (Carryn et al., 
2003). Even though P. salmonis is sensitive to a variety of antibiotics in vitro (Mikalsen et al., 
2008), the situation is not the same in vivo, presumably due to insufficient concentration of 
antibiotics within the host. Still treatment with antimicrobial drugs is the main therapy against 
piscirickettsiosis (Cvitanich et al., 1991). There are only four antibiotics in the Norwegian 
aquaculture that are used to treat fish pathogens: florfenicol (only for salmon), oxolinic acid 
(salmonids) and sulphadiazin/trimethoprim (finfish) (Norwegian Medicines Agency, 2014). In 
regard to P. salmonis infection, orally administered oxolinic acid is the drug of choice, even 
though the response is slow and it has to be given repeatedly (Fryer and Hedrick, 2003). A lot 
of the antibiotics tested in vitro cannot be used in aquaculture because they are used to treat 
human diseases. According to the Center of food safety, the use of antibiotics may lead to 
bacterial resistance which will undermine the effectiveness of those antibiotics in treating 
human illnesses.   
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Using antibiotics can cause a number of side effects such as development of resistant bacterial 
strains and pollution of the environment. Antibiotics can be administrated in fish cultures by 
immersion baths, feed or injections. However, since there are several disadvantages with the 
delivery of antibiotics to the fish, finding an effective vaccine for piscirickettsiosis is 
preferable, but only a small number of vaccine trials have been reported. This does not mean 
that they do not exist, but are rather undisclosed by the private actors. Attempts to use whole-
cell bacterins have shown variable results (Kuzyk et al., 2001b, Smith, 1995). In addition, 
vaccines trails based on formalin-inactivated and heat-inactivated cells have been established 
(Birkbeck et al., 2004b). However, better protection was observed when a recombinant 
vaccine was established (Kuzyk et al., 2001a), and it did not take long before the next vaccine 
based on a mixture of recombinant proteins was introduced into the market (Wilhelm et al., 
2006). At present, there are 33 commercially injectable vaccines against piscirickettsiosis 
available in Chile, where 29 are inactivated vaccines and 4 are subunit vaccines. In total, 2 of 
these vaccines are oral and 31 are injectable (Rozas and Enríquez, 2013). The vaccines have 
variable long-term efficacy, but at least they protect the fish after transfer of fish from fresh 
water to seawater. After this the fish are susceptible to a second, more aggressive form of 
piscirickettsiosis, which has proved to be much more difficult to protect the fish against 
(Tobar et al., 2011).   
To find a therapy against piscirickettsiosis, more research is needed both on the pathogenesis 
and within vaccine development. A possible pathogenesis factor that might be important for 
P. salmonis is the outer membrane vesicles (OMVs), which are naturally produced by gram-
negative bacteria (Collins, 2011). These vesicles have previously been used successfully as 
vaccines (Park et al., 2011) and have shown to give protective immunity against other fish 
pathogens, including Francisella noatunensis (Brudal, 2014). The interest in the OMVs as 
vaccines has expanded, and it is possible that they can be used as a vaccine against 
piscirickettsiosis in the future. However, to further study potential vaccine candidates against 
P. salmonis, further studies of the pathogenesis is needed, and this might be provided by the 
establishment of more advanced infection models, like the extensively studied zebrafish 
embryo model.  
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1.3 Zebrafish as a model system   
The zebrafish (Danio rerio) is a small tropical fresh-water fish that is popular in aquariums. 
They are usually characterized by its white and dark stripes, and can reach a size up to 5 cm in 
length as adults. The zebrafish has been known since 1822, but in 1960 it was discovered as 
an excellent model for research (Sullivan and Kim, 2008). The fish offers several advantages 
as an animal model: they are one of the smallest vertebrate animals with a fully developed 
adaptive and innate immune system, require minimal laboratory space, they have short 
generation time- a single female can produce up to 200-300 embryos per mating, easy 
maintenance, low cost, fully sequenced genome, availability of transgenic lines (Fig. 1.3.1) 
and molecular research tools. Interestingly, the innate immune system is functional early in 
zebrafish maturation, with macrophages and neutrophils active by 48 hours post fertilization 
(Allen and Neely, 2010). The adaptive immune system on the other hand is not fully 
developed for another 4-6 weeks (Lam et al., 2004). This enables an opportunity to study the 
innate immune system without the interference of the adaptive immune system.   
Furthermore, embryos develop externally and- due to their transparency at the embryo- and 
early larval stage, many processes can be visualized using light microscopy (Meeker and 
Trede, 2008). Some mutant strains maintain their transparency throughout life (White et al., 
2008). Using these fish lines in combination with fluorescently labeled pathogens allows real-
time in vivo observations of disease progression (Phelps and Neely, 2005). Moreover, fish 
lines are established that possesses fluorescently labeled immune cells, like macrophages or 
neutrophils. Here, fluorescent labeling can provide essential information about early stages of 
infection and the interaction between the pathogen and the immune cells of the fish.   
 
Fig. 1.3.1: Adult zebrafish, wild type strain AB (upper left corner) and some of the different transgenic lines 
(White et al., 2008). The wild type strain AB has three distinct classes of pigment cells arranged in stripes: black 
melanophores, reflective iridophores and yellow xanthopores. The nacre strains lack the melanocytes, while the 
roy strains lack the iridophores. Finally, the casper strains complete lack of all melanocytes and iridophores.    
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There are only few things that are not fully accomplished in the zebrafish model. These are 
the lack of antibodies against zebrafish proteins and difficulties in establishment of isolated 
cell cultures (Meeker and Trede, 2008). Remarkably, the zebrafish immune system is quite 
similar to humans and other vertebrates, which makes it a versatile model (Howe et al., 2013). 
The zebrafish has also been proven to be a robust model for studying pathogenesis, host-
pathogen interactions at several stages of the infection; screening, drugs and vaccines. To 
exemplify, the zebrafish has been used to study intracellular pathogens, such as 
Mycobacterium marinum (Swaim et al., 2006) an extensively used model for human 
Mycobacterium tuberculosis infections and Francisella (Brudal et al., 2014), which has 
provided important information in regard to their pathogenesis.  
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2 Aims of the study 
P. salmonis was only recently, for the first time, grown independent of cell lines. Thus, little 
is still known about P. salmonis growth and pathogenesis. 
The main goal of this Master‘s thesis was therefore to: 
1. Establish growth of the different P. salmonis strains in the laboratory. 
2. Make fluorescently-labeled GFP mutants strains. 
3. Establish a P. salmonis-zebrafish embryo infection model. 
4. Treat piscirickettsiosis by nanoparticle encapsulation of antibiotics. 
This will be a starting platform for research on P. salmonis and subsequent treatment against 
piscirickettsiosis.  
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3 Materials and methods  
3.1 Bacterial strains, media and growth conditions   
The three isolates of P. salmonis used in this study was a kind gift from Duncan J. Colquhoun 
(Oslo, NVI) (Table 3.1.1). These bacteria were routinely cultured at 20°C on Eugon 
Chocolate Agar (ECA), containing 30.4 g/L BD Bacto 
TM
 Eugon Broth (Becton, Dickinson 
and Company, Franklin lakes, NJ, USA), 15 g/L Agar Bacteriological (Thermo Fisher 
Scientific, Hudson, NH, USA) and 5% bovine blood (Håtunalab AB) or in liquid culture 
(EBFC) with BD Bacto 
TM
 Eugon Broth supplemented with 2 mM FeCl3 (Sigma-Aldrich Co., 
St. Louis, MO, USA) and 1% Casamino Acids (BD). Bacteria were kept at -80°C for long 
term storage in autoclaved 10% skimmed milk (BD Difco) or in BD Bacto 
TM
 Eugon Broth 
supplemented with 20% glycerol (Sigma-Aldrich). Additionally, E.coli was routinely cultured 
at 37 °C on Luria Agar (LA-plates) and in Luria Broth (LB-media).   
Table 3.1.1: Bacterial strains used in this study. 
Isolate Species isolated from Country 
P. salmonis   
P. salmonis NVI 5692 Atlantic salmon (Salmo salar) Norway 
P. salmonis NVI 5892 Atlantic salmon (Salmo salar) Canada 
P. salmonis 5896 Unknown Unknown 
   
E.coli   
E.coli S17.1   
3.2 Identification of P. salmonis by 16S rRNA 
sequencing 
The strains used in this study were identified as P. salmonis by 16S rRNA sequencing. 
Boiling preparation was made of P. salmonis 5692, 5892 and 5896 and a nested polymerase 
chain reaction (PCR) amplification was carried out. Primers used in this study are given in 
more detail in Table 3.2.1. In the first round of amplification the bacterial 16S primers, EubA 
and EubB (GIBCO®, Invitrogen, Paisley, UK) were used and P. salmonis specific primers, 
PS2S and PS2AS from the same manufacturer were used in the second round. The PCR 
reaction was set up using Dynazyme screening master mix which contained Dynazyme ӀӀ 
DNA polymerase (Thermo scientific), and 2 µl template DNA from each strain were used in 
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the reaction. In addition, boiling preparation of E.coli S17.1 was used as a control and 
negative controls were made without any template DNA. The mixture was denatured at 95°C 
for 5 minutes, amplified with 35 cycles of 94°C for 30 seconds, 50°C for 40 seconds, 72°C 
for 40 seconds and finally the last extension step of 72°C for 5 minutes in a GeneAmp PCR 
system 2700- PCR machine (Applied Biosystems, Foster City, CA, USA.). For the second 
round of amplification, 2 µl of the first round of reaction was used as a template. The mixture 
was denatured at 95°C for 5 minutes, amplified with 35 cycles of 94°C for 30 seconds, 61°C 
for 40 seconds, 72°C for 40 seconds and finally the last extension step of 72°C for 5 minutes. 
All samples were examined for specificity on a 1% agarose gel (Sigma-Aldrich) and the gel 
products were cleaned from the gel by following E.Z.N.A gel extraction kit (Omega Bio-Tek, 
Norcross, GA) (see appendix B: Kit protocols). DNA concentration and purity were measured 
with a Picodrop spectrophotometer (Picodrop Ltd, Cambridge, UK) and the products were 
then sent to sequencing (ABI-lab, IBV, UiO). 
Table 3.2.1: Primers used in 16S rRNA sequencing. 
Primer Sequence Specificity 
EubB 5‘-AGAGTTTGATCMTGGCTCAG-3‘ Eubacterial 
EubA 5‘-AAGGAGGTGATCCANCCRCA-3‘ Eubacterial 
PS2S 5‘-CTAGGAGATGAGCCCGCGTTG-3‘ P. salmonis 16S 
PS2AS 5‘-GCTACACCTGCCAAACCACTT-3‘ P. salmonis 16S 
3.3 Antibiotic susceptibility 
P.  salmonis 5692, 5892 or 5896 was grown in Eugon broth supplemented with 2mM FeCl3 
and 1 % Casamino Acids. Each strain was plated evenly on two ECA plates (3 ml per plate) 
and excess of liquid was removed. The bacterial culture on the plates was allowed to solidify 
on the bench and different antibiotic tablets, with 6 tablets per plate (Table 3.3.1), were placed 
on the plates. Growth was observed after one week incubation at 20 °C and a zone of 
sensitivity was measured around each tablet.   
Table 3.3.1: Antibiotic tablets used to test antibiotic susceptibility by a disc-diffusion method. 
Abbreviations Antibiotic Tablet 
concentration (µg) 
Manufacturer 
G-25 Sulfisoxazole 250 µg BD 
C-30 Chloramphenicol 30 µg BD 
Mec-10 Mecillinam 10 µg BD 
GM-30 Gentamycin 30 µg BD 
16 
 
SXT Sulfamethoxazole/trimethoprim 23.75 µg/1.25 µg BD 
Ox-5 Oxacillin 5 µg BD 
Te-30  Tetracyclin 30 µg BD 
Cip-5 
Am-10 
SD-25 
CN-30 
SMX 
Rif-5 
Ciprofloxacin 
Ampicillin 
Sulfadiazine 
Cephalexin 
Sulfamethoxazole 
Rifampicin 
5 µg 
10 µg  
250 µg 
30 µg 
23.75 µg 
5 µg 
BD 
BD 
BD 
BD 
BD 
BD 
3.4 Growth curves 
P. salmonis 5692, 5892 or 5896 was cultured in 10 ml of liquid media and incubated at 20 °C 
with gentle shaking (100 rpm) in an Innova 4230 incubator and shaker (New Brunswick 
Scientific, Edison, NJ, USA). Optical density (OD) at 600 nm was measured three times a day 
with a Bio Photometer (Eppendorf AG, Hamburg, Germany). The optimal OD600 of the 
inoculum was determined by diluting the culture at different ODs in 50 ml medium. The 
determined optimal inoculum was then used further for growth curves measurements of each 
strain. Samples were taken out from the liquid culture every second day and plated evenly on 
an ECA plates to check for contaminations.     
Growth of P. salmonis was in addition tested after starvation in autoclaved seawater and 
during alterations in access to light to further evaluate the effects of different conditions on 
growth in liquid medium. The cultures were incubated at 20 °C, and when they reached an 
appropriate OD600, the cultures were diluted and incubated at the various growth conditions, 
as described in Fig. 3.4.1.     
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Fig. 3.4.1: P. salmonis 5692, 5892 or 5896 was cultured in 10 ml EBFC or seawater. After reached an 
appropriate OD600, the bacteria were diluted in EBFC or seawater, under different access to light. OD600 was 
measured three times a day, and checked regularly for contaminations.  (Figure made by Julia Tandberg). 
3.5 Colony Forming Units 
P. salmonis 5692, 5892 or 5896 was cultured in 10 ml of liquid media and incubated at 20 °C 
with gentle shaking (100 rpm). After growth to optimal inoculum, the cultures were diluted in 
50 ml media and OD600 was measured three times a day. Serial dilutions were made of each 
OD600 and 10 µl of each dilution were plated onto the same ECA plate. The plates were 
incubated at 20 °C and the colony forming units (CFU) were counted after approximately 1-2 
weeks.  
3.6 Plasmid isolation  
P. salmonis 5692, 5892 or 5896 was grown in 10 ml media at 20 °C and 100 rpm to a dense 
culture in the middle of exponential phase. The bacteria were centrifuged at 4500 rpm for 5 
minutes in a Rotina 420R (Hettich zentrifugen, Buckinghamshire, UK) and the presence of 
natural occurring plasmids were evaluated by following the manufacturer’s instructions in the 
E.Z.N.A® Plasmid Mini Kit I (Omega Bio-Tek) (see appendix B: Kit protocols). Plasmid 
concentration and purity were measured with the Picodrop spectrophotometer and visualized 
on a 1% agarose gel.  
3.7 Isolation and analysis of outer membrane 
vesicles 
Outer membrane vesicles (OMVs) were isolated from 100 ml dense cultures in the late 
exponential growth phase of P. salmonis 5692, 5892 or 5896. Cells were removed from 
suspension by centrifugation at 11500 rpm in an Avanti
TM
 J-25 cooling centrifuge (Beckman 
Coulter Inc., CA, USA) at 4 °C for 10 minutes. The supernatant was collected and filtered 
through a 0.45 µm filter (GE Healthcare Life Sciences, Buckinghamshire, UK) and a 0.22 µm 
filter (GE Healthcare). The supernatant was then ultra-centrifuged in a Sorvall
®
Discovery
TM 
100 (Sorvall products, L.P, Newtown, USA), 37 ml supernatant per tube, for 2 hours at 25900 
rpm, 4 °C. The supernatant was discarded, and the pellet was washed with 37 ml cold 50 mM 
N-2-hydroxyethylpiperazine-N9-ethanesulfonic acid (HEPES) buffer pH 6.8 (see appendix A: 
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Solutions). The samples were ultra-centrifuged for an additional 30 minutes at 25900 rpm (4 
°C) to pellet the OMVs. The supernatant was discarded and the OMVs were resuspended in 
100 µl 1x phosphate buffered saline (PBS) pH 7.2 (see appendix A: Solutions). OMV aliquots 
(25 µl) were then stored at -80 °C for later use. In addition, one aliquot was spread on an ECA 
plate and incubated at 20 °C for at least three weeks to ensure sterility.  
To check the content of the OMVs, aliquots were separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). The OMVs were mixed with sampling 
buffer (see appendix A: Solutions), and 20 µl of this mix was loaded onto a gel (Thermo 
Scientific). The gel was run at 60V for 15 minutes, followed by 100V for 1 hour. The gel was 
then moved to a container for Coomassie-Blue staining (see appendix A: Solutions) and 
destaining (see appendix A: Solutions). Subsequently, the gel was rinsed with MQ water and 
viewed in a Molecular Imager
®
 Gel Doc 
TM 
XR+ (Bio-Rad Laboratories, Inc., CA, USA). In 
addition, the protein contents of the OMVs (non-dilution, 10x and 100x dilutions of samples) 
were electro blotted onto a polyvinylidene difluoride (PVDF) membrane (GE Healthcare). 
The membrane was then blocked in 5 % skim milk (BD Difco) for 1 hour at room 
temperature on a Stuart roller mixer SRT9 (Bibby Scientific, Staffordshire, UK). Primary 
antibodies (Rabbit-anti-P. salmonis K231) were a kind gift from Duncan J. Colquhoun and 
was used to immunoblott the membrane at 4 °C overnight and thereafter incubated in Goat 
Anti-rabbit IgG (H+L)-HPR conjugate (Bio-Rad) for 1 hour at room temperature. 
Luminata
TM
Crescendo Western HRP Substrate detection solution (EMD Millipore, MA, 
USA) was added onto the membrane to give enhanced chemiluminescence and incubated for 
5 minutes. Excess of fluid was removed and the membrane was wrapped in plastic to prevent 
it from drying out. The membrane was then exposed and viewed in a Chemi Genius 2 Bio 
Imaging System (Syngene, Cambridge, UK). 
3.8 Electron microscopy of P. salmonis and outer 
membrane vesicles 
P. salmonis cell surface structures were analyzed by using transmission electron microscopy 
(TEM) and scanning electron microscopy (SEM) in collaboration with the Electron 
microscopy unit at the Department of Bioscience, UiO.   
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Analysis of cell surface structures in TEM; P. salmonis 5692, 5892 or 5896 from liquid 
culture, directly from plate and fixation in liquid culture with a mix of 4 % paraformaldehyde 
(PFA) (Sigma-Aldrich) and 0.5 % glutaraldehyde (Sigma-Aldrich) were tested. The bacteria 
were centrifuged and resuspended in 0.2M cacodylate buffer (see appendix A: Solutions). The 
bacteria suspensions were then incubated with Carbon coated Formvar copper grids (200 
mesh, hexagonal) (Electron microscopy unit, IBV, UiO) for 10 minutes. The grids were 
washed three times with cacodylate buffer, four times with distilled water (dH2O), and 
negatively stained with 1.5 % uranyl acetate (UA) for 2 seconds. Then the grids were washed 
once with dH2O and finally stabilized with (9:1) methyl-cellulose in UA for 10 minutes on 
ice. The grids were then dried and viewed in a Phillips CM200 transmission electron 
microscopy.       
Analysis of cell surface structures in SEM; P. salmonis 5692, 5892 or 5896 from liquid 
culture and directly from plate were incubated on pre-coated poly-lysine (Sigma-Aldrich) 
coverslips (Thermo Scientific). The coverslips were then fixed overnight at 4 °C with 2 % 
glutaraldehyde in 0.1M sodium cacodylate buffer pH 7.4. They were then washed two times 
in the same buffer for 10 minutes each. The samples were dehydrated in a graded ethanol 
series for 10 minutes at 70, 90, 96 and 100 % and 15 minutes 4 rinsing in 100 % ethanol. 
Dehydrated samples were subsequently critical-point dried using carbon dioxide in a CPD 
030 critical-point dryer (Bal-Tec, CA, USA), then mounted on stub with carbon-circles 
colloidal silver and sputter coated with a Cressington coating system 308R. The samples were 
then viewed in a Hitachi S-4800 scanning electron microscopy, and the images were acquired 
using Scandium software. 
The isolated OMVs were viewed in TEM; Carbon coated Formvar copper grids (100 mesh, 
hexagonal) (Electron microscopy unit, IBV, UiO) were incubated on an OMV solution from 
P. salmonis 5692, 5892 or 5896 for 5 minutes and then washed three times with PBS. 
Accordingly, the samples were fixed in 1 % glutaraldehyde (Sigma-Aldrich) for 4 minutes, 
washed three times with PBS, two times with Milli-Q (MQ) water, negatively stained for 1 
minute with 4 % UA (Sigma-Aldrich), washed once with MQ water and finally stabilized 
with a solution of (9:1) methyl-cellulose (Sigma-Aldrich) in UA for 10 minutes on ice. The 
grids were then dried and viewed in a Philips CM200 transmission electron microscope and 
the images were acquired using iTEM software. Professor Norbert Roos from the Electron 
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microscopy unit at the Department of Bioscience (UiO) handled the microscope and took the 
images of the bacteria and the isolated OMVs. 
3.9 Infection of CHSE-214 cells 
Chinook salmon embryo-214 cell line (CHSE-214) were seeded onto coverslips (Thermo 
Scientific) in six-well plates (Thermo Scientific) with cell growth medium (3 ml per dish): 
Leibovitz L-15 medium (Bio Whittaker, Wokingham, UK) supplemented with 10 % fetal 
bovine serum (FBS) (Bio Whittaker), 40 µM β-Me (Gibco BRL, Uxbridge, UK), 4 mM L-
glutamine (Gibco) and 50 µg/µl gentamycin sulfate (Bio Whittaker). Each well had a density 
of 100 000 cells and they were incubated at 20 °C in a Termaks incubator (Thermo Scientific) 
for 6 days to reach a 50-70 % confluence. Prior to infection with P. salmonis 5692, 5892 or 
5896 the cell growth media were removed and replaced with media not containing 
gentamycin sulfate. Bacteria from EBFC liquid cultures were centrifuged at 7176 g for 2 
minutes, resuspended in cell growth medium without gentamycin sulfate, and adjusted to OD 
0.6 before 200 µl bacterial suspension was added to each well. The cells were then incubated 
in medium without gentamycin sulfate at 20 °C in the Innova 4230 incubator under different 
light and dark conditions until 2, 5 or 10 days post-infection. The cells were fixed using 4 % 
PFA (Sigma-Aldrich) and then kept in PBS. The cells were permeabilized for 5 minutes with 
0.1 % triton X-100 (Sigma-Aldrich) in PBS, followed by two times washing with 0.01 % 
TWEEN® 20 detergent (Calbiochem, Merck, Germany) in PBS. The cells were then blocked 
for 30 minutes with 5 % goat serum (Molecular probes by life technologies, Invitrogen) in 
0.01 % TWEEN® 20 (blocking solution). Rabbit-anti-P. salmonis was diluted in blocking 
solution (1:200) and cells were incubated in the solution for 1 hour at room temperature. 
Subsequently, the cells were stained with a solution of goat-anti-rabbit Alexa green 488 
antibody (1:500) (Molecular probes
®
, Invitrogen), wheat germ agglutinin (WGA) (1:250) 
(Molecular probes
®
, Invitrogen) and 4’.6-diamidino-2-phenylindole (DAPI) (1:1000) 
(Molecular probes
®
, Invitrogen) in blocking solution for 1 hour at room temperature. Cells 
were washed twice with 0.01 % TWEEN® 20 and coverslips were mounted on objective 
glasses (Thermo Scientific) with 1 drop ProLong® gold antifade reagent (Molecular Probes
®
, 
Invitrogen). The objective glasses were incubated at room temperature in the dark overnight, 
and for long term storage at 4 °C in the dark. The cells were then analyzed further in a 
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fluorescence microscope and confocal microscope (see 3.14 Fluorescence microscopy 
section).     
3.10 Zebrafish embryo care and maintenance 
Zebrafish (Danio rerio) embryos used in this study were purchased from Peter Aleström‘s 
zebrafish facility at The Department of Basic Sciences and Aquatic Medicine, Norwegian 
University of Life Sciences. Different zebrafish embryos strains were used; the wild type 
strain AB, casper (roy
-/-
;nacre
-/-
) strain and other transgenic zebrafish strains expressing red 
fluorescence in neutrophils Tg(LysC:DsRED2) and macrophages Tg(mpeg1:gal4ff): 
(UAS:nfsB-mCherry). Zebrafish eggs were collected in a tube with 28 °C embryo water (see 
appendix A: Solutions) and wrapped in heat packs for transportation. The eggs were then 
transferred from Peter Aleström‘s zebrafish facility and kept at 28 °C in the Griffiths 
Zebrafish Lab at the University of Oslo. In addition, the wild type strain AB embryos used in 
this study were produced in-house. Zebrafish embryos were manually dechorionated at the 
age of 30 hours post fertilization, and kept at 28 °C prior to injections.    
3.11 Infection of zebrafish embryos with P. salmonis   
Overnight cultures of P. salmonis 5692, 5892 and 5896 were harvested by centrifugation at 
10 000 g for 10 minutes at 4 °C (Mikro200R, Hettich zentrifugen), resuspended in PBS pH 
7.4 and optical density at 600 nm (OD600) was measured by a Bio Photometer (Eppendorf 
AG). The OD600 was adjusted to a desired value with PBS and then phenol red sodium salt 
solution (Sigma-Aldrich Co) was added to a final concentration of 0.01 % to help visualize 
the injections. 
Injection needles (without filament, outer and inner diameter of 1.0 and 0.78 mm, length of 
100 mm, Harvard Apparatus, Holliston, MA, USA) were made using a Sutter needle puller 
(P-97 Flaming/Brown micropipette puller, Novato, CA, USA). The needle puller was 
installed on the following settings: delay-110, velocity-50, pull-40, heat-610 and pressure-
500.  
The needle was loaded with 10 µl bacterial suspension containing phenol red by using a 
needle-loading pipette (Eppendorf). Then the needle was attached to a micromanipulator 
(Narishige, Tokyo, Japan) and a pressure controller ((FemtoJet, Eppendorf). To unseal the 
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needle, the needle was submerged in mineral oil (Sigma) and the tip was broken off by using 
sharp forceps. The volume was determined by doing trial injections into the oil, and the 
diameter of the red droplets was measured with a ruler incorporated into an eyepiece of the 
microscope. The volume for infection of the embryos should be approximately 1 nl. The wild 
type strain AB or the transgenic zebrafish embryos 48 hours post fertilization (hpf) were 
anesthetized using a water bath supplemented with approximately 170 µg/ml Tricaine 
methanesulfonate MS-222 (Tricaine) pH 7.4 (Argent Laboratories Group, Inc., Redmond, 
WA, USA). After 1-2 minutes, the embryos were transferred to a 2 % agarose (BD) injection 
plate and excess water was removed to immobilize the fish. Fish were injected in the Duct of 
Cuvier (Fig. 3.11.1), and the injections were deemed successful if the phenol red could be 
observed in the blood circulation following injection (Fig. 3.11.2).  
 
Fig. 3.11.1: Zebrafish embryo 48 hpf with an arrow showing the injection site in this study; Duct of Cuvier. 
Figure is taken from: http://www.neuro.uoregon.edu/k12/Part%202.html .  
 
 
Fig. 3.11.2: Successful infection of a zebrafish embryo; can see the phenol red spreading into the blood 
circulation. This figure is made by David Westmoreland during his Master‘s thesis in Gareth Griffiths group 
(UiO).   
Infected fish were transferred into new petri dishes with fresh embryo water and kept at 22 
°C. The embryos in this study were used for monitoring survival, visualization of bacterial 
infection route, whole-mount immunohistochemistry or gene expression analysis by 
quantitative PCR. For survival experiments, approximately 20 embryos per group were 
injected with P. salmonis 5692, 5892 or 5896 in PBS with OD600 of 0.5 and 2.0. In addition 
PBS without bacteria supplemented with phenol red was used for injections as negative 
controls. 
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3.12 Calcein AM staining of P. salmonis 5692 and 
injections into zebrafish embryos 
P. salmonis 5692 was centrifuged at 7176 g for 2 minutes, resuspended in 1 ml PBS pH 7.4 
and OD600 was adjusted to OD600 2.0 in 500 µl PBS. The suspension was then incubated for 
15-20 minutes with 30 µl acetoxymethyl diacetylester of calcein (Calcein AM) (1 mM 
Calcein AM (Molecular Probes®, Invitrogen) in dimethyl sulfoxide (DMSO) (Sigma-
Aldrich®). Approximately 10 zebrafish embryos of each strain Tg(LysC:DsRED2) and 
Tg(mpeg1:gal 4ff):(UAS:nfsB-mCherry) was injected in the Duct of Cuvier with the bacterial 
suspension supplemented with phenol red by Lilia Ulanova. The embryos were then analyzed 
further in a confocal microscope after 1 hour (see 3.14 Fluorescent microscopy section).                         
3.13 Whole-mount immunohistochemistry of 
zebrafish embryos  
Wild type strain AB zebrafish or casper (roy
-/-
;nacre
-/-
) embryos were injected in the Duct of 
Cuvier with P. salmonis 5692, 5892, 5896 or with PBS as controls. The embryos were 
incubated at 22 °C, and the wild type strain AB zebrafish were in addition reared in 0.003% 
of 1-phenyl-2-thiourea (PTU) (Sigma), to reduce the pigmentation. At day 0, 1, 3 and 6 post 
infections, the embryos were euthanized in ice bath, and in tricaine bath. The embryos were 
then washed in PBS and fixed in 2 % trichloroacetic acid (TCA) (TCA powder in dH20) for 3 
hours at room temperature. After fixation, the embryos were washed carefully three times for 
5 minutes with PBS, and stored for long term storage at 4 °C in 500 µl PBS. 
In this study, 5 fish were used for each days post infection (dpi) and each bacterial strain. The 
embryos were transferred into an 8-well lab-Tek® glass chamber slide (Thermo Scientific) 
with 2-3 fish per each chamber, washed twice with PBT (0.8 % triton X-100 in PBS) at room 
temperature and chilled on ice. PBT was then replaced with 200-300 µl cold 0.25 % trypsin 
(2.5 % Trypsin (10X), GIBCO®, Invitrogen) in PBT, and incubated on ice for 4 minutes (2-3 
days old embryos), 5 minutes (3-4 days old embryos) or 6 minutes (5-6+ days old embryos). 
The trypsin solution was immediately replaced with PBT supplemented with 10 % goat serum 
(blocking solution) and incubated at room temperature for 5 minutes. The embryos were then 
washed three times for 5 minutes at room temperature. Nonspecific binding sites were 
blocked with 10 % goat serum in PBT for 1 hour at room temperature on a GFL 3005 orbital-
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shaker (DJB Labcare, Buckinghamshire, UK) with gentle agitation around 40 rpm. In the 
meantime, the primary antibody (Rabbit-anti-P. salmonis) was diluted in PBT with 10 % goat 
serum (1:200). Subsequently, the blocking solution was replaced with diluted primary 
antibody, and incubated overnight at 4 °C on a rocking table with gentle agitation. The 
antibody was then removed, and washed over several hours with PBT. PBT was changed at 
least five times, and finally the embryos were washed with PBS. The secondary antibody 
(Goat-anti-rabbit Alexa red 594) was then diluted in PBT containing 10 % goat serum 
(1:500), and the PBS were replaced with the secondary antibody solution and the samples 
were incubated overnight at 4 °C with gentle agitation. The embryos were kept in the dark 
from this stage, to avoid bleaching of the samples. Subsequently, the antibody was removed 
and washed with PBT over several hours with five changes of PBT. Finally, PBT was 
removed and embryos were stained with DAPI in PBS (1:1000), and incubated at room 
temperature for 10 minutes. The DAPI was then removed, and PBS added to the embryos. 
The zebrafish embryos were then analyzed further in a fluorescence and confocal microscope 
(see 3.14 Fluorescent microscopy section). 
3.14 Fluorescence microscopy  
Wholemount samples and some of the CHSE-214 cells were analyzed in a Nikon Eclipse 
TE300 fluorescence microscope (Nikon Instruments, NY, USA). The samples were viewed 
by using a Nikon Intensilight C-HGFI (Nikon Instruments), and images were acquired using 
NIS-Elements BR 3.0 software (Nikon Instruments). The images were then further analyzed 
on the Fiji platform.  
Olympus Fluoview
TM
 FV1000 Confocal Microscope (Olympus Europa Holding GmbH, 
Hamburg, Germany) was also used to do live-imaging of zebrafish embryos infected with 
calcein AM stained P. salmonis 5692 and to analyze the CHSE-214 cells. Lilia Ulanova at the 
Department of Bioscience (UiO) handled the microscope and took the images. Images were 
acquired using Olympus Fluoview
TM
 version 3.1 software (Olympus Europa Holding GmbH) 
and further processed on the Fiji platform. Fluorophores used to study the cell infection was 
488 (Alexa green), 594 (WGA) and 405 (DAPI). On the day of analysis five random 
overview pictures were taken from each strain of P. salmonis at day 5 post infection, in light 
and dark respectively and controls. The number of bacteria per cell was counted manually, to 
investigate a possible difference in infection rate in light versus dark. In addition, two pictures 
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from each sample were taken at a higher magnification (60X) to confirm that the bacteria 
were inside the cells. In addition, wholemount samples were further analyzed by three 
dimensional confocal imaging at NVI in corporation with Even Thoen. A Zeiss LSM 710 
confocal microscope (Carl Zeiss, Jena, Germany) was used to assess and visualize the 
bacteria and staining; images were acquired using LSM software ZEN (Carl Zeiss) version 
2009. Fluorescence from DAPI was excited at 405 nm by a Diode laser and fluorescence from 
Alexa 594 at 514 nm by an Agron laser. 
3.15 Zebrafish embryo immune response to P. 
salmonis 5692 infection 
Zebrafish embryos Tg(LysC:DsRED2) were injected with calcein AM-stained P. salmonis 
5692 and Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos were injected with calcein AM-
stained and non-stained P. salmonis 5692. In addition, PBS was injected as a control. At each 
time point (day 1 and 6 post infection, plus PBS control), 9 randomly chosen zebrafish 
embryos from each group was euthanized by an overdose of Tricaine solution (200-300 
µg/ml). The embryos were transferred into 1.5 ml Eppendorf tubes (Eppendorf), three 
embryos in each tube. Then, the embryo water was replaced by RNALater (Ambion by Life 
Technologies
TM
, Carlsbad, CA, USA) immediately after the transfer. The samples were kept 
for long term storage at 4 °C until extraction of RNA. For the extraction of total RNA, 
RNALater was replaced with 600 µl buffer RLT (supplemented in RNeasy Mini Kit, 
QIAGEN). The samples were homogenized by using a mortar and pestle (Sigma-Aldrich), 
followed by a blunt 20 gauge needle fitted to a small 1 ml syringe (BD), and the lysate was 
passed at least five times through the needle on the syringe. Subsequently, the samples were 
centrifuged at full speed for 3 minutes (Mikro200R) and the RNA-containing supernatant was 
mixed with an equal volume of 70 % ethanol (Kemetyl, Vestby, Norway), and loaded on 
RNEasy Mini Spin columns (QIAGEN GmBH, Hilden, Germany). The samples were 
thereafter handled according to the manufacturer’s instruction, including a 15 minute on-
column DNase treatment using RNase-free DNAse set (QIAGEN) (see appendix B: Kit 
protocols). RNA was finally diluted in 30 µl RNAse-free H2O (QIAGEN). RNA quantity and 
quality was measured with a Picodrop spectrophotometer. Reverse transcription reaction was 
performed by using High Capacity RNA to cDNA kit (Applied Biosystems) (see appendix B: 
Kit protocols). Maximum amount of 9 µl RNA per reaction was used. In addition, negative 
26 
 
control of each sample was made to confirm the absence of genomic DNA. The samples were 
handled according to the manufacturer‘s instruction, including incubation of the reaction at 37 
°C for 1 hour, stopping the reaction by heating to 95 °C for 5 minutes and then hold at 4 °C. 
This was done in a GeneAmp PCR system 2700 PCR machine and cDNA were ready for 
quantitative PCR (qPCR) or could be kept for long-term storage at -20 °C.   
Primers (Table 3.15.1) were chosen to target a repertoire of the immune response from 
zebrafish: TNF-α, IL-1β, IL-8, IL-10, IFNg1-2 and socs3b, in addition the reference genes 
18S rRNA and EF1α were used to normalize the relative transcription level.  
Table 3.15.1: Primers used for qPCR in the experiment. 
Gene name Gene symbol Manufacturer 
18S rRNA zgc:158463 Invitrogen 
elongation factor 1-alpha ef1α Invitrogen 
tumor necrosis factor a tnfα QIAGEN 
interleukin 1, beta il1b QIAGEN 
interleukin 8 il8 QIAGEN 
interleukin 10 il10 QIAGEN 
interferon, gamma 1-2 ifng1-2 QIAGEN 
suppressor of cytokine signaling 3b socs3b QIAGEN 
 
The primers were used in a concentration of 5 µM, and the cDNA was diluted (1:10) in MQ-
water. Quantitative PCR was performed in duplicates using a Lightcycler® 480 (Roche, 
Basel, Switzerland) qPCR machine (software: Lightcycler® 480 version 15.1.62) in 20 µl 
reactions volume containing Lightcycler® 480 SYBR Green Ӏ Master (Roche), 0.5 µM of 
each primer and 5 µl template. The qPCR machine was set at following conditions: 5 minutes 
denaturation at 95 °C, 45 cycles amplification with 10 seconds at 95 °C, 30 seconds at 60 °C 
and 8 seconds at 72 °C. The cycle threshold (CT) values were analyzed in Microsoft Excel 
2010, in addition to analysis of melting curve to verify single amplification peaks. Statistical 
analyses were performed in GraphPad Prism 6.   
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4 Results             
4.1 Growth studies and identification of P. salmonis 
by 16S rRNA sequencing 
The different P. salmonis strains were obtained from the Veterinary Institute (NVI) (Oslo). 
16S rRNA sequencing was then performed on P. salmonis to ensure that further experiments 
include the correct bacterium. After the 16S rRNA sequencing, the sequences were obtained 
from ABI-lab, IBV, UiO and analyzed by the basic local alignment tool (BLAST). According 
to the data (Fig. 4.1.1), the strains used in this study was identified as P. salmonis with a 98 % 
identity, when the query sequence was compared to sequences in the database. All three P. 
salmonis strains were analyzed, but only the data for P. salmonis 5692 (NVI 5692) is 
presented here as they all gave similar result. Sequences for the other two P. salmonis strains 
are presented in appendix (see appendix C: Other results).  
 
Fig. 4.1.1: Sequences alignments for P. salmonis 5692 from BLAST. 
Alignments of the query sequence (138 bp) with the subjected sequence for P. salmonis 5692 
(NVI 5692) (420 bp) is shown in more details in Fig. 4.1.2. There are only three nucleotides 
in the query sequence that do not fit to the subjected sequence in the database. Therefore, P. 
salmonis 5692 used in this study, are P. salmonis 5692 with a 98 % identity. However, the 
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subjected sequence in the database is a partial sequence and there may be uncertainties around 
the sequence. In addition, the 138 bp query sequence is only matching a part of the 420 bp 
subjected sequence.     
 
Fig 4.1.2: Sequence obtained after 16S rRNA sequencing from P. salmonis 5692 (query sequence) is compared 
to a subjected sequence in the database. The subjected sequence already in the database was isolated in another 
study (Mikalsen et al., 2008) from P. salmonis strain NVI 5692 16S ribosomal RNA gene, partial sequence. Y 
and S in the sequence alignment means that more than one kind of a nucleotide can occur at that position: Y = 
nucleotide T or C and S= nucleotide G or C.    
After the confirmation of P. salmonis by 16S rRNA sequencing, growth studies were 
performed. Due to the scarce information available as to how to grow the bacterium, different 
media such as CHAB– and ECA plates in addition to Eugon broth with and without iron and 
casamino acids at different temperatures were tested. Optimal growth was obtained by using 
the EBFC liquid medium and ECA plates and the ideal temperature of P. salmonis was 
determined by measuring growth at 18 °C, 20 °C and 23 °C. Of the incubation temperature 
tested, no growth was observed for any of the three P. salmonis strain at 23 °C while growth 
were visible at 18 °C after 5 days incubation on ECA plates. Optimal growth was observed at 
20 °C, and individual colonies were then visible after 5-7 days incubation. The colonies were 
around 1 mm in diameter, slightly convex, shiny and grey-white. In the EBFC liquid medium 
the cultures went from bright, clear, yellow color to a dense and opaque color at 20 °C after 2-
4 days incubation, with a shaking of 100 rpm. 
4.2 Antibiotic susceptibility 
Establishment of how P. salmonis respond to different antibiotics in vitro was tested with the 
disc-diffusion method on ECA plates incubated at 20 °C (Table 4.2.1). A zone of sensitivity 
was measured around each tablet; the larger the area of no growth surrounding the tablet the 
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more sensitive the bacteria were to the drug. The data suggested that all three strains of P. 
salmonis were sensitive to almost all of the antibiotics tested, except for sulfadiazine. P. 
salmonis 5896 was in addition resistant to sulfamethoxazole/trimethoprim and 
sulfamethoxazole.  
Table 4.2.1: Antibiotic susceptibility test: Various antibiotics were tested for P. salmonis 5692, 5892 and 5896. 
The star symbol (    ) = the diameter of the no growth zone around the antibiotic tablet was too large to measure 
due to P. salmonis sensitivity towards the various antibiotics.  
 
Antibiotic 
 
Tablets  
of  
 
P. salmonis  
5692  
P. salmonis 
 5892 
P. salmonis 
 5896 
Zone  
of no  
growth  
Resistance Zone  
of no  
growth 
Resistance Zone  
of no  
growth 
Resistance 
Sulfisoxazole 
 
250 µg  -  -  - 
Chloramphenicol 
 
30 µg  -  -  - 
Mecillinam 
 
10 µg  -  -  - 
Gentamycin 
 
30 µg  -  -  - 
Sulfamethoxazole/ 
trimethoprim 
23.75µg/ 
1.25 µg 
 -  -  
Growth 
+ 
Oxacillin 
 
5 µg  -  -  - 
Tetracyclin 
 
30 µg  -  -  - 
Ciprofloxacin 
 
5 µg 
 
 -  -  - 
Ampicillin 
 
10 µg  
 
 -  -  - 
Sulfadiazine 
 
250 µg 
 
 
Growth 
+  
Growth 
+  
Growth 
+ 
Cephalexin 
 
30 µg 
 
 
3.0 cm 
-  
3.5 cm 
-  
3.0 cm 
- 
Sulfamethoxazole 
 
23.75 µg 
 
 -  -  
Growth 
+ 
Rifampicin 
 
5 µg  
1.5 cm 
-  
1.0 cm 
-  
0.8 cm 
- 
4.3 Growth curves and CFU  
It has been shown that optimal growth is dependent on the size of the inoculum (Augustin et 
al., 2000). An inoculum is the number of bacteria used in an inoculation of a new liquid 
culture. To test whether the inoculum had an effect on the growth of P. salmonis; different 
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OD600 was used to inoculate a new liquid culture and growth was measured. The results from 
the inoculum test for the three P. salmonis strains are shown in Fig. 4.3.1.  
 
 
 
Fig. 4.3.1: Inoculum test of P. salmonis strains to find optimal OD600 to use as an inoculum for growth curves.  
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P. salmonis 5692 and 5896 needed an inoculum of OD600 2.38 and 4.8 respectively, and P. 
salmonis 5892 needed a higher inoculum between OD600 3 and 7. Based on the optimal OD600 
of the inoculum, growth curves were made of all three P. salmonis strains (Fig. 4.3.2). 
According to Fig. 4.3.2 P. salmonis 5896 has a lag phase from 0-25 hours, exponential phase 
from 26-47 hours, stationary phase from 48-72 hours and then it reaches the death phase. The 
stationary phase begins at OD600 12 and ends around OD600 15. P. salmonis 5892 is slower 
growing than the other two strains, as it needs more time to reach the high OD600 values.  
 
Fig. 4.3.2: Comparison of growth curves between P. salmonis 5692, 5892 and 5896. All cultures were 
maintained in EBFC medium in light at 20° C and 100 rpm (n= 3).     
When growth measurements were performed, an interesting observation was noticed. It 
seemed like P. salmonis grew better in the dark and slower in the light. An experiment was 
therefore preformed to further evaluate the observation. The study was based on Gómes-
Consarnau‘s work where they demonstrated that a Vibrio strain was dependent on light for 
survival in stress conditions such as seawater (Gómez-Consarnau et al., 2010). The 
experiment set up is showed in Fig. 3.4.1, and the results after starvation in seawater (SW) 
and during alterations in access to light are shown in Fig. 4.3.3. According to Fig. 3.4.1, some 
of the bacteria from each strain were only cultured in seawater. No growth was observed or 
measured for these bacteria (Fig. not shown). The same was the case for P. salmonis 5896, 
which were first cultured in seawater, then in EBFC. This experiment was only tested once, 
compared to other experiments which were at least performed three times. However, 
according to Fig. 4.3.3, P. salmonis could survive in seawater for a period of time, and during 
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this period they preferred the light. However, after transferring the bacteria from the 
starvation period in seawater to EBFC medium, they preferred the dark.  
A.
 
B.
 
C.
 
D.
 
E.
 
Fig. 4.3.3: Comparison of growth curves between P. salmonis 5692, 5892 and 5896 (A-E), when the bacteria had 
starved and been cultivated in different alterations in access to light (figure made by Julia Tandberg). The growth 
curve of P. salmonis 5896 from seawater is not shown because no growth could be detected. In A: The green 
graph coincides with the purple graph (n= 1). 
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Sometimes it is of relevance to relate OD to actual cell numbers or- colony forming units for 
each OD (Fig. 4.3.4). For example, it can be important to know the approximate amount of 
bacteria added to cells or injected into fish in infection studies. According to Fig. 4.3.4, OD 
corresponds to approximately the same CFU for the different P. salmonis strains.  
 
Fig. 4.3.4: The figure shows the relationship between CFU/ml and OD for P. salmonis 5692, 5892 and 5896. All 
cultures were maintained in EBFC medium (n= 3).     
4.4 Plasmid isolation 
One of the goals in the thesis was to make fluorescently GFP-labeled bacteria, which turned 
out to be a difficult assignment. Different plasmids and methods were used; electroporation, 
heat-shock transformation and cryo-transformation, without any success, even though the 
method conditions were changed. Therefore, plasmid isolation was performed to test whether 
P. salmonis have naturally occurring plasmid(s) which could be an explanation for the 
difficulties in transforming P. salmonis with broad spectrum plasmid vectors known to 
replicate in at least 41 other Gram-negative bacterial species (Blatny et al., 1997, Thomas and 
Helinski, 1989). Recently the genome sequence for P. salmonis LF-89 was published, but 
without report of any plasmid in the sequence. However, after isolation of the plasmids from 
all three P. salmonis strains, they were visualized on a 1% agarose gel. The gel clearly 
showed separate bands for each strain (Fig. 4.4.1), which indicates that P. salmonis have 
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naturally occurring plasmids. There are little differences in the plasmid profile between the 
strains, and the sizes of the plasmids are at least over 10 kB compared to the DNA ladder.  
 
Fig. 4.4.1: Agarose gel electrophoresis of naturally occurring plasmids isolated from P. salmonis strain 5692, 
5892 and 5896. Well 2 and 3: Plasmids isolated from P. salmonis 5692. Well 4 and 5: Plasmids isolated from P. 
salmonis 5892. Well 6 and 7: Plasmids isolated from P. salmonis 5896.    
4.5 Electron microscopy  
Due to the successful establishment of growing P. salmonis strains in EBFC liquid medium, it 
was of natural interest to investigate the shape and size of the bacteria in the electron 
microscope to investigate any potential phenotypic difference between the strains. Analysis of 
phenotypic structures was first performed in TEM (Fig. 4.5.1). Different methods were tested; 
preparation directly from a liquid culture, fixation in liquid culture before preparation or 
directly from plate. All methods led to bacterial collapsing, and the images where the bacteria 
were prepared directly from plates; had too much noise. However, fixation in liquid culture 
before preparation gave best results, due to less collapsing and noise. Only the image of P. 
salmonis 5896 (fixed directly into the liquid culture) is shown as there was no apparent 
difference between the strains. By TEM analysis they all appeared round in shape with 
indications of a rippled membrane. However, many of the bacteria had collapsed and lost their 
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structure. This collapse might be caused by the sensitivity to uranyl acetate (UA) that was 
used as a negative stain in the preparation of the bacteria, or by loss of bacterial integrity in 
the buffered solution. Thus, only 1.5 % UA was used in the preparations and the grids were 
incubated for only one second. In addition, methyl-cellulose with UA was tried to avoid the 
collapsing unfortunately without too much success (Fig. 4.5.1).        
 
Fig. 4.5.1:  TEM analysis of P. salmonis 5896 
The cell surface of P. salmonis was also studied by SEM. Two preparation methods were 
used in SEM: preparation directly from a liquid culture and directly from plate. In the images 
where the bacteria were prepared directly from plates detailed cell surface analysis was 
inhibited by the secretion of bacterial extracellular material. However, it was possible to see 
signs of the formation of a biofilm of P. salmonis (Fig. 4.5.2 D). The best result was obtained 
when the bacteria were taken directly from a liquid culture and incubated on coverslips. The 
pictures clearly show that P. salmonis have a strong, ruffled membrane; they are coccoid and 
interestingly structure that bare resemblance to vesicles formation (Fig. 4.5.2 A-C). The 
observation of these outer membrane vesicles (OMVs) led to further studies. 
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A. 
 
B. 
 
 
C. 
 
 
D. 
 
 
Fig. 4.5.2: SEM images of the cell surface structure of P. salmonis. A: P. salmonis 5692 from liquid culture. B 
and C: P.salmonis 5892 from liquid culture. D: P. salmonis 5896 from agar plate.    
4.6 Analysis of outer membrane vesicles from P. 
salmonis 
After the observation by SEM that P. salmonis secretes membrane vesicles, they were 
attempted isolated by standard protocols. Subsequent isolated OMVs had a yield of 3.5-4 
mg/ml from P. salmonis 5692 and 5896, and 2.0 mg/ml for P. salmonis 5892. After the 
isolation; they were analyzed by TEM, to verify the size and morphology (Fig. 4.6.1). The 
OMVs appeared the same for all three P. salmonis strains; numerous, intact and spherical 
shape at different sizes_ between 20-200 nm.  
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Fig. 4.6.1: TEM images of OMVs isolated from P. salmonis 5896.  Left image: An overview of the vesicles. 
Right image: The size and shape of the vesicles.  
4.7 Protein content analysis of outer membrane 
vesicles  
Further analyses of the OMVs were performed by SDS-PAGE and Western blotting. Several 
abundant proteins of different sizes from the OMVs were detectable by Coomassie Blue 
staining after separation by SDS-PAGE (Fig. 4.7.1). The protein pattern was roughly the same 
from all P. salmonis strains, and in addition the same pattern was confirmed with Western 
blotting. The gel picture from Western blotting is not shown due to poor quality and 
resolution of the image.   
 
Fig. 4.7.1: Analysis of the protein content in the outer membrane vesicles by Coomassie Blue staining after 
separation by SDS-PAGE.  
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4.8 Infection of CHSE-214 cells 
According to the literature (Fryer et al., 1992), P. salmonis can infect CHSE-214 cells. This is 
also true for P. salmonis strain 5692, 5892 or 5896 as tested here (Fig. 4.8.1). Previous 
experiment in this study has shown that P. salmonis thrives in the dark; therefore it was of 
interest to investigate if it was a difference in infection of CHSE-214 cells in light and dark. 
Manually counting of cells and bacteria inside and outside of the cells were performed. This 
will give an estimation of the infection properties of the bacteria; the more bacteria that are 
inside the cells, the greater is the infection. The infection in light and dark can then be 
followed, and whether P. salmonis thrives in the dark in vivo can also be tested. The counting 
was possible due to different staining of the CHSE-214 nucleus (blue), the membrane (red) 
and the bacteria (yellow/green). The bacteria were easily separable from dust and auto 
fluorescence, due to the larger and reproducible size of the bacteria. The bacteria inside and 
outside could then be counted, in addition to the number of CHSE-214 cells (Fig. 4.8.1 A). 
Furthermore, a graph was made to see if there was a striking difference in infection in light 
and dark (Fig. 4.8.1 C). According to the graph, P. salmonis 5892 and 5896 have around 10-
15 % higher infection in the dark. In addition, 3D images were taken to confirm that the 
bacteria were in fact inside the cells, and not on the top or below the cells. Fig 4.8.1 B, clearly 
illustrate that the bacteria were inside the cells. All of these results were obtained at day 5 
post-infection.  
A.  
 
B.  
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Fig. 4.8.1: P. salmonis infection in CHSE-214 cells at day 5, OD= 0.6, analyzed by a confocal microscope. A: 
Random chosen overview picture of P. salmonis 5896 infection of CHSE-214 cells performed in dark. Blue= 
nucleus of CHSE-214 cells, red= CHSE-214 cell membrane and yellow= P. salmonis 5896. The nuclei are 
labeled with number 3, bacteria that are outside are labeled with number 2 and the bacteria that are inside are 
labeled with number 1. B: Higher magnification of one CHSE-214 cell infected with P. salmonis 5896 in the 
dark. The arrows indicate the border of the cell membrane and the green bacteria are marked with yellow circles. 
C: The graph illustrates the difference between infection in light and dark for each P. salmonis strain. The Y-axis 
indicates the percentage of bacteria that are intracellular and extracellular respectively.  
4.9 Zebrafish embryo survival test 
For the establishment of a P. salmonis-zebrafish embryo infection model; wild type strain AB 
zebrafish embryos were infected with P. salmonis 5692, 5892 or 5896 in PBS with OD600 of 
0.5 and 2.0. Approximately 20 embryos per group were injected, and in addition a group of 
embryos were injected with PBS as controls. The result of the survival test was the same for 
the different P. salmonis strains; therefore only the result for embryos infected with P. 
salmonis 5692 is presented (Fig. 4.9.1). Only two fish died, irrespective of the infection dose 
(OD600= 0.5 or 2), therefore the curve coincides (Fig. 4.9.1). All fish survived among the 
embryos injected with PBS illustrating that the injection itself was not the reason for deaths 
among the embryos.  
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Fig. 4.9.1: Survival experiment of wild type strain AB zebrafish embryos infected with P. salmonis 5692 at an 
OD600 of 0.5 and 2 by microinjection. Control embryos were injected with PBS. Each group consisted of 20 
embryos, and the embryos were observed daily for mortalities (n= 2). 
4.10 Infection of Calcein AM-stained P. salmonis 
5692 
As the experiments to genetically transform P. salmonis strains with GFP plasmid failed, 
other methods to follow and visualize P. salmonis infections were tried. Calcein AM is a stain 
that rapidly enters viable cells and thereby gets hydrolyzed inside the cytoplasm where a part 
of the molecule is removed; it, has previously been used for example to stain retinal ganglion 
cells (Grieshaber et al., 2010). Calcein AM-stained P. salmonis 5692 was injected into 10 
zebrafish embryos of Tg(LysC:DsRED2) (red fluorescent protein expressing neutrophils) or 
into Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) (red macrophages). After 1 hour the embryos 
were viewed in the confocal microscope in real-time (Fig. 4.10.1). Tg(mpeg1:gal4ff): 
(UAS:nfsB-mCherry) embryos with red macrophages had phagocytosed green labeled 
bacteria. In addition, it was observed that the bacteria attracted more macrophages in the 
blood stream. On the other hand, Tg(LysC:DsRED2) with red neutrophils; no or little 
interactions were observed between the neutrophils and the injected bacteria (data not shown).  
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B.
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D. 
 
Fig. 4.10.1: All the imaging has been done in the trunk area of the zebrafish embryo (A), specifically in the 
caudal hematopoietic tissue (CHT). B-D: Red fluorescent macrophages in the zebrafish that have taken up the 
green calcein AM-stained P. salmonis 5692. Images taken by Lilia Ulanova in the confocal microscope.   
In the establishment of a zebrafish infection model it is of importance to investigate the 
immune response of the host to the infection. Thus the immune response from the same fish 
lines used in imaging was investigated by RT-qPCR by methods previously established by the 
group for Francisella subspecies (Brudal et al., 2014). First the immune response was 
analyzed for the infection of the Tg(LysC:DsRED2) fish line injected with calcein AM-
stained P. salmonis 5692. Surprisingly most immune genes were downregulated in the 
infected fish compared to the PBS control (see appendix C: Other results). Therefore, 
Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos injected with calcein AM-stained and non-
stained P. salmonis 5692 was analyzed to determine if calcein AM itself had an effect on the 
immune response (see appendix C: Other results). The results obtained indicate that the 
immune response may be virtually non-existent and calcein AM may have an effect. 
However, based on the data obtained it is not possible to draw any conclusions and the 
experiment will have to be repeated.     
4.11 Whole-mount immunohistochemistry 
Another method to investigate the intracellular localization of P. salmonis in the zebrafish is 
by whole-mount immunohistochemistry. The casper (roy
-/-
;nacre
-/-
) zebrafish embryos were 
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injected with P. salmonis 5692, 5892 or 5896 and PBS. At day 0, 1, 3 and 6 post infections, 
the embryos were euthanized and analyzed with whole-mount immunohistochemistry. By this 
method the embryos were made fluorescent in blue with DAPI and the bacteria were 
fluorescently red using immunofluorescent antibodies. Only the result of one fish infected 
with P. salmonis 5692 is presented (Fig. 4.11.1), because there was no apparent difference 
between the P. salmonis strains. The only difference to be detected was between the different 
days when the embryos were euthanized. Of the several parallel fish from each day they all 
showed the same results; it took some time for the bacteria to grow inside the fish, and it was 
not until day 6 post infection that the bacteria had grown to an extent that allowed detection 
inside the fish. To verify that the bacteria were indeed inside the fish, confocal images were 
taken (Fig. 4.11.1 E). This picture confirmed the in vivo localization of the bacteria inside the 
fish, and it showed that one single fluorescent signal actually was aggregates of 10-15 
bacteria. In contrast, the PBS control injected fish were free of bacteria.             
 
Fig. 4.11.1: P. salmonis 5692 infection of zebrafish embryo analyzed by a fluorescence or confocal microscope. 
A: Embryo at 0 day post infection. No indication of bacterial infection is evident. B: Embryo at 1 day post 
infection. Some indication of red fluorescently labeled bacteria is evident (arrows). C: Embryo at 3 day post 
infection. The red bacteria are marked with arrows. D: Embryo at 6 day post infection. The red bacterial clumps 
are inside the fish (arrows). E: Confocal image of the infected fish at day 6 post infection. The muscles are on the 
sides of the spinal cord and are adjacent to the point where the red bacteria are located. The red fluorescent 
signal consists of 8-10 bacteria in one aggregate. F. Control fish injected with PBS at day 6 post infection; no red 
fluorescently labeled bacteria are visible.        
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5 Discussion 
The basis of P. salmonis infection and pathogenesis is not known, and further research on the 
bacterium is needed. Thus, the scientific field on P. salmonis has expanded, due to the 
spreading, deleterious disease caused by the bacterium. This Master‘s thesis describes the 
study on the fish pathogen P. salmonis; its growth and investigation to its pathogenesis. This 
was achieved using the advantages of the zebrafish model system and growth was tested using 
standard microbiology methods.  
5.1 Identification of P. salmonis by 16S rRNA 
sequencing and its growth conditions 
There are many reasons why the 16S rRNA gene sequences can be used to study bacterial 
phylogeny and taxonomy; it is present in all bacteria, the function of the 16S rRNA gene has 
not changed over time, the 16S rRNA gene is large enough for informatics purposes and the 
method is easy and economical to perform (Janda and Abbott, 2007). Additionally, the 
primary structure of the 16S rRNA is highly conserved, and species that have 70 % or greater 
DNA similarities usually have more than 97 % sequence identity (Stackebrandt and Goebel, 
1994). Therefore, if two sequences have a similarity above 97 %; it can be considered that 
they belong to the same species. However, even this high sequence similarity may not be 
sufficient in all instances to guarantee an accurate identification. Janda and Abbott (2007) 
demonstrated that even though the type strains of Edwardsiella species exhibit 99.35 to 99.81 
% similarity to each other; they are still clearly distinguishable biochemically and by DNA 
homology (Janda and Abbott, 2007). Many other genomic regions have also been used to 
identify the phylogenetic relationships among bacteria (Clarridge, 2004) such as whole-
genome analysis, 16S-23S rRNA gene internal transcribed spacer sequences and 23S rRNA 
sequences. 16S rRNA sequencing is still the most preferable method, and this method was 
used in the thesis and previously in the literature (Rozas and Enríquez, 2013) to identify P. 
salmonis. Once P. salmonis 5692, 5892 and 5896 were confirmed to be P. salmonis by 16S 
rRNA sequencing, further studies were undertaken. The quality of obtained sequences 
allowed identification of the bacteria, and P. salmonis 5692 was identified as P. salmonis NVI 
5692 with a 98 % identity. After this confirmation, growth studies were performed.  
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Optimal growth conditions for P. salmonis were found by testing the bacterial cultures at 
different temperatures and culture mediums. Mikalsen et al. (2008) were the first to report the 
ability of P. salmonis to grow on agar plates supplemented with 5 % ovine blood (CHAB) 
(Mikalsen et al., 2008). P. salmonis were shown to have an optimal growth at 22 °C, and the 
colonies reached 1 mm in diameter by day 6. However, present study demonstrated that P. 
salmonis grew faster on ECA plates at 20 °C, and colony size measurement was impossible 
on day 6 as the colonies growth was too dense. Thus better conditions for P. salmonis growth 
were found as compared to previously reported. There are other reports regarding the optimal 
growth medium for P. salmonis (Yanez et al., 2013, Henriquez et al., 2013). Henriquez et al. 
(2013) demonstrated growth of P. salmonis LF-89 up to a maximum OD600 value of 1.7 only 
within 37.5 hours on a blood-free bacteriological medium with yeast extract and peptone. 
This growth rate is 3 times faster than those reported previously. The P. salmonis strains 
tested in this study could grow to an OD600 value of 12-16 in the EBFC medium within 40-72 
hours. Whether the type strain P. salmonis LF-89 also can grow in this medium or why the 
strains tested in the thesis could grow to such high OD600 values is not known. The three P. 
salmonis strains tested in this study were found not to grow up to high OD600 values in the 
EBFC medium without casamino acids (EBF medium) even though it was suitable for another 
fish pathogen Francisella (Brudal et al., 2013). Perhaps the casamino acid mixture contains 
essential amino acids or a specific ingredient, which in combination with iron, makes the 
environment favorable for the bacteria. At least, it is known that iron is essential for almost all 
living organisms because it is involved in a wide variety of important metabolic processes. 
Iron is not available for bacteria and therefore they need to employ various iron uptakes from 
their surroundings (Wooldridge and Williams, 1993). Most intracellular bacteria need iron, 
and of course, amino acids. The casamino acids mixture can provide most of the essential 
nutrients, and it has been used previously to culture bacteria such as Lactobacillus (Van Niel 
and Hahn-Hägerdal, 1999). However, further studies are needed to find the specific ingredient 
of casamino acids that is essential for P. salmonis growth. This can be further investigated by 
successively removing one of the ingredients of the casamino acid mixture which will reveal 
the amino acid(s) that is the most important for bacterial growth. Additionally, no antibiotics 
were used in the medium due to the sensitivity of P. salmonis to most of the antibiotics tested 
in the thesis. Therefore creating a bacterial strain with an antibiotic resistance would be one of 
the appealing directions to allow growing P. salmonis selectively.  
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5.2 Antibiotic susceptibility 
One of the most important routines for microbiological laboratories is the performance of 
antibiotic susceptibility testing on bacterial isolates. There are several methods available to do 
this testing such as broth dilution test, antimicrobial gradient test, disc-diffusion test or with 
automated instruments (Reller et al., 2009). The disc-diffusion test was chosen in the thesis 
because the method has previously been used to test P. salmonis antibiotic sensitivity in the 
literature (Mikalsen et al., 2008). The disc-diffusion method is a simple test that does not 
require any special equipment, it is a low-cost method and one can be flexible in selection of 
discs for testing. However, the test cannot be automatized and not all fastidious or slow 
growing bacteria can be accurately tested by this method (Reller et al., 2009). The results 
obtained after the performance of a disc-diffusion method indicated that P. salmonis are 
sensitive to a variety of antibiotics in vitro, in agreement with data reported earlier (Mikalsen 
et al., 2008, Fryer et al., 1992). In this thesis, P. salmonis appeared to be resistant only to 
sulfadiazine and sulfamethoxazole out of 13 antibiotics that have been tested. Even though the 
bacterium is sensitive to antibiotics in vitro, the situation is not always the same in vivo 
(Rozas and Enríquez, 2013). This is most likely due to the fact that the bacterium is 
intracellular, and perhaps insufficient concentration of antibiotics reaches the bacteria within 
the host. Therefore, P. salmonis should be grown in the absence of antibiotics as their 
presence can affect the results obtained during growth measurements.   
5.3 Growth curves and CFU  
P. salmonis 5692, 5892 and 5896 tested in the thesis had similar growth curves (Fig. 4.3.1) 
with P. salmonis 5892 being the slowest growing strain. When the bacteria reached their 
optimal OD600 for inoculation, the cultures were diluted to an OD600 0.02 and left to grow. 
This is followed by so-called lag phase, the time required by cells to synthetize and to 
accumulate metabolite(s) that are essential for growth and division (Lankford et al., 1966). 
Therefore, the length of this phase depends directly on the growth phase of the inoculum. 
Additionally, Augustin et al. (2000) demonstrated that the duration of the lag phase for 
Listeria monocytogenes depends strongly on the size of the inoculum (Augustin et al., 2000). 
The lag time increased with a decreased inoculum size of previously starved cells. The 
different P. salmonis strains tested in the thesis, also had lag phase duration dependent on the 
size of the inoculum. P. salmonis 5892 needed a high inoculum to decrease the lag phase, 
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while P. salmonis 5892 and 5896 needed a lower inoculum. The average lag phase for the 
three P. salmonis strains are approximately from 0-25 hours with an OD600 of 0-1. According 
to Fig. 4.3.3 an OD600 of 1 correspond to approximately 10
10
 CFU/ml for each P. salmonis 
strain. The lag phase is followed by rapid bacterial growth called exponential phase. For P. 
salmonis, this phase lasts approximately from 26-47 hours. When all the essential nutrients in 
the growth medium are used up and the reproduction rate is slow or non-existent, the bacteria 
enter the stationary phase. This phase happens after 48-72 hours with some variations within 
the different P. salmonis strains. Eventually the bacteria proceed to the death or logarithmic 
decline phase. After approximately 72 hours, all of the three P. salmonis strains tested in this 
study were in this phase. Additionally, liquid cultures of the different P. salmonis strains with 
the same OD600 had almost the same CFU/ml ratio during the whole growth process. 
The following experiment was initiated due to an interesting observation that P. salmonis 
grows faster during the night with no light exposure. The bacterial growth after starvation in 
seawater was observed with and without light exposure in EBFC medium. As shown in Fig. 
4.3.2 P. salmonis could survive in seawater for a period of time, and in this condition they 
grew more when exposed to light. However, after the transfer from the seawater to the rich 
EBFC medium, the bacteria grew faster in the dark. Once proven correct by repetition, this 
result can initiate further studies to find the biological reason behind this phenomenon. This 
finding could imply a circadian rhythm of P. salmonis, even though the bacterium is non-
photosynthetic. Soriano et al. (2010) reported an heterotrophic bacterium Pseudomonas 
putida, that showed regular variations in its growth pattern synchronized with light/darkness 
cycles (Soriano et al., 2010), which could be an advantage in certain environments. The 
authors cultured the bacterium on agar medium containing either Coomassie brilliant blue or 
Congo red. These dyes bind proteins and other extracellular polymeric substances; allows 
direct visualization of surface changes appearing during colony growth in light and dark. This 
experiment was repeated in the thesis; however, no difference in growth pattern in light and 
darkness has been indicated (results not shown).    
Another possible theory is that the light and dark cycle of P. salmonis is caused by 
membrane-embedded, light-driven proton pumps called proteorhodopsins. These pumps 
translocate protons across the membrane, generating available energy in the form of 
adenosine triphosphate (ATP) (Gómez-Consarnau et al., 2010). Gòmez-Consarnau et al. 
(2010) showed that marine Vibrio species that contain proteorhodopsins, display light-
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enhanced survival during starvation in seawater. Furthermore, bacteria that have been starved 
in the light could respond more rapidly to improved growth conditions faster than those that 
have been incubated in the dark. Gòmez-Consarnau et al. (2010) investigated this 
phenomenon by creating proteorhodopsins deficient Vibrio strain and managed to 
demonstrate that the light-dependent survival after starvation were in fact mediated by the 
proteorhodopsins. Whether this is the case for P. salmonis remains unclear, and further 
studies are needed to confirm the light and dark cycle.  
5.4 Plasmid isolation 
Plasmids are small, typically circular, double-stranded DNA molecules that are distinct from 
the cellular chromosomal DNA and can exist in three conformations: supercoiled, open-
circular and linear (Jong et al., 1997). There are no reports of P. salmonis plasmids in the 
literature. It was only recently that- the first draft genome sequence of P. salmonis LF-89 was 
published (Eppinger et al., 2013). 
Plasmid isolation was performed due to problems with making fluorescently GFP-labeled P. 
salmonis. Different transformation methods such as electroporation, heat-shock and cry-
transformation were used, in addition to different vector plasmids, without any success 
(results not shown). The results obtained after the plasmid isolation clearly shows that P. 
salmonis have naturally occurring plasmids (Fig. 4.4.1). Naturally occurring plasmids can 
sometimes block the replication of the vector plasmid if the vector plasmid is related 
genetically to the naturally occurring plasmid- incompatible plasmids (Velappan et al., 2007). 
Even though, a method called plasmid curing with ethidium bromide was performed in the 
thesis to eliminate the naturally occurring plasmid, it was unsuccessful (results not shown). 
Another possible reason for the transformation problem is that the vector plasmid may need a 
P. salmonis promoter to be able to recognize and replicate the plasmid, and thereby 
expressing the green-fluorescent insert in the vector plasmid. To obtain this, the naturally 
occurring plasmid needs to be sequenced, which is an ongoing experiment. The gel capture 
(Fig. 4.4.1) shows little differences in plasmids composition between the strains, and the sizes 
of all the plasmids are at least over 10 kB. The plasmids are most likely low-copy number, 
and it remains unclear whether there are several plasmids of the same size, plasmids of 
different sizes or only one plasmid. What genes the genome and the plasmid contain is not 
certain, or whether there is a difference between the strains. The purpose the plasmids serves 
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in P. salmonis is not known, but usually the plasmids give a genetic advantage for the 
bacteria, such as a unique metabolism or antibiotic resistance. The P. salmonis strains tested 
in the thesis were quite similar in regard to antibiotic sensitivity, growth conditions and 
plasmids. Therefore, it was also interesting to test whether the different bacteria strains were 
similar in size and shape.     
5.5 Size and shape of P. salmonis and OMVs  
The size and shape of P. salmonis is widely reported to be coccoid with a size of 0.5-1.5 µm 
(Fryer et al., 1990, Fryer et al., 1992, Fryer and Hedrick, 2003). The present study using SEM 
and TEM confirmed that the bacteria are coccoid with indications of a rippled membrane. 
There was no apparent difference in size or shape between the studied strains. In addition, 
observations by SEM revealed other biological structures, such as a biofilm and vesicles.  
Biofilms are formed when bacteria are organized into a structure on solid surface and 
surround themselves with exopolysaccharide matrix (Costerton et al., 1999). The biofilm 
formation by P. salmonis may be an response to stress as it has been reported in the literature, 
e.g. P. salmonis produce biofilm to cope with stress and survive in marine waters (Marshall et 
al., 2012).   
Outer membrane vesicles (OMVs) are normally produced during the bacteria life span and 
used for the communication between different individuals, which most likely plays an 
important role in P. salmonis pathogenesis. Outer membrane vesicles are spherical lipid 
bilayer blebs that are formed by budding from the outer bacterial membrane and contain 
lipopolysaccharides (LPS) and periplasmic proteins (Kulp and Kuehn, 2010). OMVs are 
usually 10-300 nm in diameter. Previously, OMVs were thought to be depleted in inner 
membrane and cytoplasmic components (Katsui et al., 1982), but a recent report indicate that 
they might contain cytoplasmic proteins and inner membrane in along with DNA (Perez-Cruz 
et al., 2013). Some pathogenic bacteria load their OMVs with virulence factors e.g adhesins 
and toxins, and these vesicles can then be delivered to distant host cells (Kuehn and Kesty, 
2005). Since the OMVs in their native state contain surface-exposed antigens e.g. porins or 
LPS (pathogen-associated molecular patterns), they are able to stimulate Toll-like receptors 
on the surface of phagocytes and thus trigger immune response (Collins, 2011). OMVs appear 
to be safe as vaccines, and they have previously been given to humans infected with Neisseria 
meningitidis type B with great success (Collins, 2011). It has in addition been shown that P. 
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salmonis can produce OMVs in cultured rainbow trout head kidney macrophages (McCarthy 
et al., 2008).  
The OMVs produced by the bacteria in liquid culture were isolated and analyzed in the thesis. 
The obtained yield varied between the different strains. The isolated OMVs from P. salmonis 
5692 and 5896 had a yield of 3.5-4 mg/ml, and P. salmonis 5892 had around 2.0 mg/ml. The 
lower yield for P. salmonis 5892 is probably due to slower growth rate of this strain compared 
to the other two. Subsequently, the size and shape of OMVs was analyzed by TEM. The 
OMVs observed by TEM were numerous, intact, spherical, and at different sizes between 20-
200 nm. There are no reports on OMVs protein composition and their function.  
However, the protein composition and function in the OMVs from other pathogens has been 
studied more extensively. Pierson et al. (2010) performed a proteomic analysis of the OMVs 
from a related fish pathogen Francisella. The authors demonstrated several proteins involved 
in pathogenesis and secretion system such as PdpA which is known to be delivered from 
Francisella to target host cells. In addition, beta lactamase were found in the OMVs, and its 
presence could help the bacterium to alter the antibiotic concentration in their external 
environment (Pierson et al., 2010). Since Francisella and P. salmonis are closely related, it 
may be that their OMVs also share similarities in regards to protein composition and may be 
their functions. In the thesis, SDS-PAGE and Western blotting showed that the OMVs 
produced by P. salmonis contained several abundant proteins of different sizes from 15 kDa 
to 100 kDa. The most abundant protein was around 37-50 kDa in size. There are ongoing 
studies in the Winther-Larsen lab to identify the OMVs protein content.      
5.6 Infection of CHSE-214 cells 
In the thesis the results obtained by Fryer et al. (1992) were confirmed, showing that P. 
salmonis are able to infect, survive and propagate inside CHSE-214 cells (Fryer et al., 1992). 
Due to the interesting growth effects seen under light and darkness conditions in this thesis, 
infection of CHSE-214 cells were also tested in light and in darkness. There are no reports in 
the literature regarding light and darkness infection of P. salmonis in fish cells. The cell count 
was performed on multiple cells and the results of the counting showed that P. salmonis tend 
to have around 10-15 % higher infection in the dark. Whether there are a statistical significant 
difference between infection in light and dark was not tested due to lack of time. Repetition of 
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the experiments is required to support these preliminary data. In addition, the bacteria were 
confirmed to be localized inside the cells by confocal imaging using Z-stack option; by using 
a conventional wide field fluorescence microscope it was hard to tell whether the bacteria 
were inside, below or on the surface of the CHSE-214 cells. Due to poor staining of the cell 
membrane and that the dye also seemed to stain bacterial membranes, the creation of 3D 
image structures was performed. By 10 days post infection, 80 % of the bacteria were inside 
the cells although by this time the cells appeared to be in poor condition, presumably due to 
consequence of the infection (result not shown). This event is called cytopathic effect (CPE) 
which is typical for P. salmonis infection (Olsen et al., 1997). In contrast, the control CHSE-
214 cells treated only with PBS were numerous and showed no signs of CPE (result not 
shown).    
CHSE-214 cells were chosen in the thesis due to the fact that this cell line is the most used 
and accepted model to culture P. salmonis LF-89 in the literature (Fryer et al., 1990, Fryer et 
al., 1992, Fryer and Hedrick, 2003). The first in vivo culture of P. salmonis was in the CHSE-
214 cell line, while there are now several reports in the literature describing P. salmonis 
replications in other fish cell line e.g Atlantic salmon kidney (ASK) cell line (Smith et al., 
2014). ASK- cells are more flat than the CHSE-214 cells, and therefore CHSE-214 cells are 
more convenient to use to check if the bacteria are inside the cells. Even though studying P. 
salmonis pathogenesis using fish cell lines can give many answers concerning pathogenesis, 
for many issues there is no substitute for using a complete organism.  
5.7 Zebrafish embryo survival test    
The zebrafish is a well-known model to study pathogenesis of different bacteria due to the 
fast development and the available transgenic lines. Additionally, the adaptive immune 
system is not fully functional until 4-6 weeks post fertilization which gives an opportunity to 
study the innate immune system apart from the adaptive. The model has previously been used 
with great success for Mycobacterium marinum (Prouty et al., 2003) and Francisella (Brudal 
et al., 2014). Using the same protocol established by Brudal et al. (2014), P. salmonis 
infection in the wild type strain AB zebrafish embryos was tested. According to the results in 
this thesis, P. salmonis infection does not cause an acute disease in this fish. An acute disease 
is characterized by a sudden onset of symptoms that usually are severe. Only two fish died in 
each experimental group out of a total of 20 fish regardless of the infection dose. No mortality 
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was observed when the fish were injected with PBS- illustrating that the injection itself was 
not the reason for deaths among the embryos. It appears that P. salmonis causes a chronic 
infection in the zebrafish embryos, reminiscent of that observed for a related fish pathogen 
Francisella noatunensis ssp. noatunensis (F.n.n) (Brudal et al., 2014). Survival experiments 
by Brudal et al. (2014) demonstrated that F.n.n infection did not lead to any significant 
mortality regardless of the amount of bacteria used for infection. This is most likely due to the 
extremely slow growth rate of this bacterium. The immune response results indicated that 
F.n.n causes a chronic infection in the zebrafish embryos. Whether this is the case for P. 
salmonis infection, remains to be shown. There are no reports in the literature as to whether P. 
salmonis is able of infect, survive and propagate in zebrafish host. In this thesis the P. 
salmonis-zebrafish embryo infection model was established. A recent pilot study done by 
Julia Tandberg, confirmed that P. salmonis can infect and cause disease in adult zebrafish 
(unpublished results). Using the different zebrafish lines in combination with fluorescently 
labeled pathogens allows real-time in vivo observations of disease progression. Due to 
difficulties in making fluorescently-labeled P. salmonis, other methods to follow and 
visualize P. salmonis were necessary.  
5.8 Infection of Calcein AM-stained P. salmonis 5692 
A dye called Calcein AM was used to color the P. salmonis 5692 membrane. Calcein AM is 
an intracellular fluorescent marker commonly used for evaluation of cell volume and 
viability. It is a vital dye that rapidly enters viable cells and then it is hydrolyzed whereby a 
part of the molecule is removed (Grieshaber et al., 2010). The molecule gets trapped inside 
the cytoplasm and emits a strong fluorescence in the green part of spectrum with light 
emission at 400-500 nm. Calcein AM is only retained within cells with an intact plasma 
membrane while- dying or damaged cells will therefore not display a fluorescent signal, 
allowing evaluation of viability (Grieshaber et al., 2010). Calcein AM was chosen because it 
has been tested on other bacteria (Dass et al., 2009) and available “in-house”. This dye stained 
the P. salmonis 5692 membrane, however not all the bacteria were stained. The reason for this 
is not known, but a possible explanation could be that; the bacteria were dead. A state of the 
P. salmonis membrane structure could also make it impermeable for the dye. In addition, after 
adding a pulse of calcein AM the stained bacteria lost the fluorescent signal after 
approximately 3 hours due to division and growth of the bacteria. 
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Despite these limitations, the early events of injection in zebrafish embryos were imaged. 
Calcein AM-stained bacteria were injected in the transgenic fish line Tg(mpeg1:gal4ff): 
(UAS:nfsB-mCherry) with red fluorescent macrophages phagocytosed the green fluorescent 
bacteria. The co-localization of bacteria and macrophages were observed as early as 1-3 hours 
post infection. This results is confirmed previously in the literature, showing that P. salmonis 
is phagocytosed by macrophages (McCarthy et al., 2008, Rojas et al., 2010, Rojas et al., 
2009). After approximately 3 hours the dye from the bacterial membrane was lost and the 
bacteria could no longer be observed in the fish. Therefore, the study in this thesis could not 
yet confirm that the bacteria replicated or escaped from the macrophage, this could only be 
possible once the bacteria have a permanent fluorescent marker. Brudal et al. (2014) 
demonstrated the co-localization of macrophage and Francisella using the transgenic 
zebrafish lines expressing red-fluorescent macrophages and the bacteria had a permanent 
fluorescent marker (Brudal et al., 2014). In this thesis, Tg(LysC: DsRED2) embryos with red 
fluorescent neutrophils were also injected with calcein-AM labeled P. salmonis 5692 showed 
no significant co-localization with bacteria. This argues that macrophages are the main cells 
responsible for phagocytosis of injected P. salmonis 5692. 
5.9 Whole-mount immunohistochemistry 
Whole-mount immunohistochemistry is a method to study intracellular localization of P. 
salmonis in the zebrafish post mortal. The method is a good alternative to study P. salmonis 
pathogenesis, but due to the fact that the fish and bacteria are dead makes it impossible to 
study how dividing bacteria behave inside a live fish. The method was based on the whole-
mount immunohistochemistry chapter in Macdonald‘s book (Macdonald, 1999), and some 
changes from this method were made in the thesis. The results indicate that P. salmonis can 
infect zebrafish embryos and it is able to grow inside the fish as increasing number of bacteria 
were observed at later time points. Another method that could be used to detect exactly the 
amount of bacteria inside a zebrafish macrophage is by flow cytometry. This method 
presumably would allow using the fluorescent signal from anti-P. salmonis antibodies and 
fluorescent signal in macrophages of transgenic zebrafish lines. Even though the method was 
established, no results were obtained yet due to the lack of time.  
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6 Conclusion 
The main conclusions that can be drawn from this Master‘s thesis are:  
 The three P. salmonis strains 5692, 5892 and 5896 were identified as P. salmonis by 
16S rRNA sequencing.  
 Procedures for growing P. salmonis strains in the laboratory were established, giving 
optimal growth of the strains used. 
 P. salmonis strains were sensitive in vitro to the majority of antibiotics tested, such as 
kanamycin.  
 Optimal OD600 of the inoculum that gave the best growth was found and growth 
curves were made. 
 The rate of growth in regard to CFU was approximately the same for all three P. 
salmonis strains. 
 P. salmonis could survive in seawater for a period of time, and in this period they 
preferred the light. However, after transferring the bacteria from the starvation period 
in seawater to EBFC medium, they preferred darkness.  
 Transfection of P. salmonis with a plasmid containing fluorescent marker appeared 
not to be feasible. 
 P. salmonis strains have naturally occurring plasmids.  
 The bacteria were confirmed to be coccoid with a rippled membrane, and biofilm- and 
vesicle formation was observed.  
 Isolated OMVs were numerous and spherical with a size of 20-200 nm. They were 
densely packed with proteins of different sizes.  
 P. salmonis strains could infect CHSE-214 cells and the infection rate was 
approximately 10 % higher in the dark.  
 A P. salmonis-zebrafish embryo infection model was established, and the model was 
shown to be useful for studies of P. salmonis infections.  
 Zebrafish macrophages were efficient in phagocytosing the bacteria shortly after 
infection, whereas neutrophils were barely or not involved.     
 Intracellular localization of P. salmonis in the zebrafish was confirmed by whole-
mount immunohistochemistry and fluorescent imaging.  
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7 Future perspectives 
Little is known about the life cycle of P. salmonis and even less data is available regarding its 
pathogenesis. Therefore future studies should focus on these topics in order to eventually find 
the cure against piscirickettsiosis.  
The pathogen itself was just recently for the first time grown independent of cell lines, which 
is a significant leap for research on this bacterium. Three P. salmonis strains were 
demonstrated to grow on agar and in liquid medium to high densities in the thesis. Whether 
other P. salmonis strains e.g the type strain LF-89 can grow on the same medium needs to be 
tested in the future. The study presented in the thesis for the first time revealed light-
sensitivity of P. salmonis, which brings plenty of new possibilities for studying the bacterial 
pathogenesis. This was only done once in the thesis and further studies are therefore needed to 
draw any conclusion.  
The study of P. salmonis pathogenesis using the zebrafish model would have been much 
easier if genetically encoded fluorescently-labeled mutant strains of P. salmonis were 
available. Attempts to make P. salmonis mutants in the group were until now unsuccessful, 
and the reason might be due to naturally occurring plasmids within the same plasmid 
incompatibility group. Sequencing of these plasmids to eventually have fluorescently labeled 
mutants is an ongoing experiment in the Hanne Winther-Larsen`s group (UiO). Infecting the 
fish with fluorescently labeled bacteria would allow in vivo imaging of early events 
happening after as well as long-term acquisition of the disease progression. In addition, 
further studies are needed in regard to immune response in fish infected with P. salmonis, 
which appeared to be delayed due to chronic nature of the infection. Therefore studies of the 
immune response at later time points are required.   
Vaccination is the only one available long-term solution intended to eliminate the threat 
caused by P. salmonis in aquaculture. Though, the vaccines that are already on the market 
show variable long-term efficiency. The market in Chile offers 33 injectable vaccines against 
piscirickettsiosis, where 29 are inactivated vaccines and 4 are subunit vaccines. There are no 
vaccines based on outer membrane vesicles produced by P. salmonis on the market yet, even 
though they look appealing. Fortunately, this is an ongoing experiment in the Hanne Winther-
Larsen`s group and will be tested in both the established zebrafish model and in salmonids in 
55 
 
the near future. Another possible solution is to test whether nanoparticle encapsulation of 
antibiotics will be a better treatment than free antibiotics. Due to lack of time, this was not 
tested in the thesis and further studies should focus on testing different encapsulation methods 
and antibiotics. Further research on this fish pathogen is important, due to the deleterious 
spreading disease which might develop into an even bigger problem for aquaculture in the 
future.                    
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Appendix 
A. Solutions: 
 1M HEPES (N-2-hydroxyethylpiperazine-N9-ethanesulfonic acid), 
pH 6.8 (1L) 
238.3 g              HEPES 
800 ml               MQ-water 
Up to 1L            MQ-water 
Adjust pH 
 PBS (phosphate buffered saline), pH 7.4 (1L) 
8 g                    Sodium chloride (NaCl) 
0.2 g                 Potassium chloride (KCl) 
1.44 g               Disodium hydrogen phosphate (Na2HPO4) 
0.14 g               Potassium dihydrogen phosphate (KH2PO4)  
Up to 1L           MQ-water 
 Protein Sample buffer 
6 ml                  10 % Sodium dodecyl sulfate (SDS) 
3 ml                  Glycerol 
1.9 ml               1M Tris-HCl pH 6.8 
0.3 ml               0.2M EDTA 
3 ml                  50 mM β-Mercaptoethanol  
0.8 ml               dH2O  
8 mg                 Bromophenol Blue  
 Coomassie Blue, 100 ml 
45 ml                  45 % Methanol 
900 µl                 0.9 % Acetic Acid 
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0.1 g                   0.1 % Brilliant Blue R 
54 ml                  MQ-water 
 Destaining buffer, 500 ml 
150 ml                30 % Methanol 
50 ml                  10 % Acetic acid 
300 ml                MQ-water 
 0.2M Sodium cacodylate buffer, pH 7.4 (1L) 
4.28 g                 Sodium cacodylate  
1000 ml            dH2O 
Adjust pH 
 Embryo water  
1.0 ml                 Hanks’ stock solution #1  
0.1 ml                 Hanks’ stock solution #2 
1.0 ml                 Hanks’ stock solution #4 
95.9 ml               H2O 
1.0 ml                 Hanks’ stock solution #5 
1.0 ml                 Hanks’ stock solution #6  
Adjusted pH to 7.2, filter sterilized and stored indefinitely at 4 °C 
 Hank‘s stock solutions  
Stock #1: 8.0 g NaCl, 0.4 g KCl, 100 ml H2O  
Stock #2: 0.358 g Na2HPO4 anhydrous, 0.6 g KH2PO4, 100 ml H2O  
Stock #4: 0.72 g CaCl2, 50 ml H2O 
Stock #5: 1.23 g MgSO4·7H2O, 50 ml H2O  
Stock #6: 0.35 g NaHCO3, 10 ml H2O  
Long term storage at 4 °C  
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B. Kit protocols: 
 E.Z.N.A.® Gel Extraction Kit - Spin Protocol 
 
1. Perform agarose gel/ethidium bromide electrophoresis to fractionate DNA fragments. Any 
type or grade of agarose may be used. However, it is strongly recommended that fresh TAE 
buffer or TBE buffer be used as running buffer. Do not reuse running buffer as its pH will 
increase and reduce yields.  
2. When adequate separation of bands has occurred, carefully excise the DNA fragment of 
interest using a wide, clean, sharp scalpel. Minimize the size of the gel slice by removing 
extra agarose. 
3. Determine the appropriate volume of the gel slice by weighing it in a clean 1.5 mL 
microcentrifuge tube. Assuming a density of 1 g/mL, the volume of gel is derived as follows: 
a gel slice of mass 0.3 g will have a volume of 0.3 mL. 
4. Add 1 volume Binding Buffer (XP2). 
5. Incubate at 60°C for 7 minutes or until the gel has completely melted. Vortex or shake the 
tube every 2-3 minutes. 
Important: Monitor the pH of the Gel/Binding Buffer mixture after the gel has completely 
dissolved. DNA yields will significantly decrease when the pH > 8.0. If the color of the 
mixture becomes orange or red, add 5 μL 5M sodium acetate (pH 5.2) to bring the pH down. 
After this adjustment, the color of the Gel/Binding Buffer mixture should be light yellow. 
6. Insert a HiBind® DNA Mini Column in a 2 mL Collection Tube. 
7. Add no more than 700 μL DNA/agarose solution from Step 5 to the HiBind® DNA Mini 
Column. 
8. Centrifuge at 10,000 x g for 1 minute at room temperature. 
9. Discard the filtrate and reuse collection tube.  
10. Repeat Steps 7-9 until all of the sample has been transferred to the column. 
11. Add 300 μL Binding Buffer (XP2). 
12. Centrifuge at maximum speed (≥13,000 x g) for 1 minute at room temperature. 
13. Discard the filtrate and reuse collection tube. 
14. Add 700 μL SPW Wash Buffer. 
Note: SPW Wash Buffer must be diluted with 100% ethanol prior to use. Please see Page 5 
for instructions. 
15. Centrifuge at maximum speed for 1 minute at room temperature. 
16. Discard the filtrate and reuse collection tube. 
Optional: Repeat Steps 14-16 for a second SPW Wash Buffer wash step. Perform the second 
wash step for any salt sensitive downstream applications. 
17. Centrifuge the empty HiBind® DNA Mini Column for 2 minutes at maximum speed to 
dry the column matrix.  
Note: It is important to dry the HiBind® DNA Mini Column matrix before elution. Residual 
ethanol may interfere with downstream applications.  
18. Transfer the HiBind® DNA Mini Column to a clean 1.5 mL microcentrifuge tube. 
19. Add 30-50 μL Elution Buffer or deionized water directly to the center of the column 
membrane. 
Note: The efficiency of eluting DNA from the HiBind® DNA Mini Column is dependent on 
pH. If eluting DNA with deionized water, make sure that the pH is around 8.5. 
20. Incubate at room temperature for 2 minutes. 
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21. Centrifuge at maximum speed for 1 minute. Note: This represents approximately 70% of 
bound DNA. An optional second elution will yield any residual DNA, though at a lower 
concentration. 
22. Store DNA at -20 °C. 
 
 E.Z.N.A.® Plasmid DNA Mini Kit I Protocol - Spin Protocol 
 
1. Isolate a single colony from a freshly streaked selective plate, and inoculate a culture of 1- 
5 mL LB medium containing the appropriate selective antibiotic. Incubate for ~12-16 hours at 
37°C with vigorous shaking (~ 300 rpm). Use a 10-20 mL culture tube or a flask with a 
volume of at least 4 times the volume of the culture. It is strongly recommended that an endA 
negative strain of E. coli be used for routine plasmid isolation. Examples of such strains 
include DH5a® and JM109®.  
2. Centrifuge at 10,000 x g for 1 minute at room temperature. 
3. Decant or aspirate and discard the culture media. 
4. Add 250 μL Solution I/RNase A. Vortex or pipet up and down to mix thoroughly. 
Complete resuspension of cell pellet is vital for obtaining good yields.  
Note: RNase A must be added to Solution I before use. Please see the instructions in the 
Preparing Reagents section on Page 6. 
5. Transfer suspension into a new 1.5 mL microcentrifuge tube. 
6. Add 250 μL Solution II. Invert and gently rotate the tube several times to obtain a clear 
lysate. A 2-3 minute incubation may be necessary. 
Note: Avoid vigorous mixing as this will shear chromosomal DNA and lower plasmid purity. 
Do not allow the lysis reaction to proceed more than 5 minutes. Store Solution II tightly 
capped when not in use to avoid acidification from CO2 in the air. 
7. Add 350 μL Solution III. Immediately invert several times until a flocculent white 
precipitate forms. Note: It is vital that the solution is mixed thoroughly and immediately after 
the addition of Solution III to avoid localized precipitation.  
8. Centrifuge at maximum speed (≥13,000 x g) for 10 minutes. A compact white pellet will 
form. Promptly proceed to the next step.  
9. Insert a HiBind® DNA Mini Column into a 2 mL Collection Tube. 
10. Add 100 μL Equilibration Buffer. 
11. Centrifuge at maximum speed for 30-60 seconds. 
12. Discard the filtrate and reuse the collection tube. 
13. Transfer the cleared supernatant from Step 8 by CAREFULLY aspirating it into the 
HiBind® DNA Mini Column. Be careful not to disturb the pellet and that no cellular debris is 
transferred to the HiBind® DNA Mini Column. 
14. Centrifuge at maximum speed for 1 minute. 
15. Discard the filtrate and reuse the collection tube. 
16. Add 500 μL HB Buffer. 
17. Centrifuge at maximum speed for 1 minute. 
18. Discard the filtrate and reuse collection tube. 
19. Add 700 μL DNA Wash Buffer. 
Note: DNA Wash Buffer must be diluted with 100% ethanol prior to use. Please see Page 6 
for instructions. 
20. Centrifuge at maximum speed for 1 minute. 
21. Discard the filtrate and reuse the collection tube. 
Optional: Repeat Steps 19-21 for a second DNA Wash Buffer wash step. 
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22. Centrifuge the empty HiBind® DNA Mini Column for 2 minutes at maximum speed to 
dry the column matrix.  
Note: It is important to dry the HiBind® DNA Mini Column matrix before elution. Residual 
ethanol may interfere with downstream applications. 
23. Transfer the HiBind® DNA Mini Column to a clean 1.5 mL microcentrifuge tube. 
24. Add 30-100 μL Elution Buffer or sterile deionized water directly to the center of the 
column membrane. 
Note: The efficiency of eluting DNA from the HiBind® DNA Mini Column is dependent on 
pH. If using sterile deionized water, make sure that the pH is around 8.5. 
25. Incubate at room temperature for 1 minute. 
26. Centrifuge at maximum speed for 1 minute. Note: This represents approximately 70% of 
bound DNA. An optional second elution will yield any residual DNA, though at a lower 
concentration. 
27. Store DNA at -20 °C. 
 
 E.Z.N.A.® Plasmid Mini Kit Protocol - Low Copy Number Plasmid 
and BAC DNA Protocol 
1. Increase the volume of starting culture from that of high copy number plasmids. Use 5-10 
mL bacterial culture for the E.Z.N.A.® Plasmid DNA Mini Kit l or 20-30 mL bacterial 
culture for E.Z.N.A.® Plasmid DNA Mini Kit ll. 
2. Pellet the bacterial cells by centrifugation. 
3. Decant or aspirate and discard the culture media. 
4. Perform Steps 4-8 in the standard protocols with double the volumes of Solution I, Solution 
II, and Solution III. 
5. Continue with Step 9 of the standard protocols by following the wash, drying, and elution 
steps. There is no need to increase the volumes of HB Buffer, DNA Wash Buffer, or Elution 
Buffer. 
 
 RNeasy Mini Kit: Purification of Total RNA from Animal Tissues 
 
1-3. Disruption and homogenization of animal tissue  
4. Centrifuge the lysate for 3 min at full speed. Carefully remove the supernatant by pipetting, 
and transfer it to a new microcentrifuge tube (not supplied). Use only this supernatant (lysate) 
in subsequent steps. In some preparations, very small amounts of insoluble material will be 
present after the 3 min centrifugation, making the pellet invisible. 
5. Add 1 volume of 70% ethanol to the cleared lysate, and mix immediately by pipetting. Do 
not centrifuge. Proceed immediately to step 6. 
Note: The volume of lysate may be less than 350 μl or 600 μl due to loss during 
homogenization and centrifugation in steps 3 and 4. 
Note: Precipitates may be visible after addition of ethanol. This does not affect the procedure. 
6. Transfer up to 700 μl of the sample, including any precipitate that may have formed, to an 
RNeasy spin column placed in a 2 ml collection tube (supplied). Close the lid gently, and 
centrifuge for 15 s at ≥8000 x g (≥10,000 rpm). Discard the flow-through. 
Reuse the collection tube in step 7. 
If the sample volume exceeds 700 μl, centrifuge successive aliquots in the same RNeasy spin 
column. Discard the flow-through after each centrifugation. 
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Optional: If performing optional on-column DNase digestion (see “Eliminating genomic 
DNA contamination”, page 21), follow steps D1–D4 (page 67) after performing this step. 
D1. Add 350 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge 
for 15 s at ≥8000 x g (≥10,000 rpm) to wash the spin column membrane. 
Discard the flow-through. 
Reuse the collection tube in step D4. 
D2. Add 10 μl DNase I stock solution (see above) to 70 μl Buffer RDD. Mix by gently 
inverting the tube, and centrifuge briefly to collect residual liquid from the sides of the tube. 
Buffer RDD is supplied with the RNase-Free DNase Set. 
Note: DNase I is especially sensitive to physical denaturation. Mixing should only be carried 
out by gently inverting the tube. Do not vortex. 
D3. Add the DNase I incubation mix (80 μl) directly to the RNeasy spin column membrane, 
and place on the benchtop (20–30°C) for 15 min. 
Note: Be sure to add the DNase I incubation mix directly to the RNeasy spin column 
membrane. DNase digestion will be incomplete if part of the mix sticks to the walls or the O-
ring of the spin column. 
D4. Add 350 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge 
for 15 s at ≥8000 x g (≥10,000 rpm). Discard the flow-through. 
Continue with the first Buffer RPE wash step in the relevant protocol. 
Note: In most of the protocols, the immediately following Buffer RW1 wash step is skipped 
(as indicated in the protocol). Continue with the first Buffer RPE wash step. 
8. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 
15 s at ≥8000 x g (≥10,000 rpm) to wash the spin column membrane. 
Discard the flow-through. 
Reuse the collection tube in step 9. 
Note: Buffer RPE is supplied as a concentrate. Ensure that ethanol is added to Buffer RPE 
before use. 
9. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge for 
2min at ≥8000 x g (≥10,000 rpm) to wash the spin column membrane. 
The long centrifugation dries the spin column membrane, ensuring that no ethanol is carried 
over during RNA elution. Residual ethanol may interfere with downstream reactions. 
Note: After centrifugation, carefully remove the RNeasy spin column from the collection tube 
so that the column does not contact the flow-through. Otherwise, carryover of ethanol will 
occur. 
10. Optional: Place the RNeasy spin column in a new 2 ml collection tube (supplied), and 
discard the old collection tube with the flow-through. Close the lid gently, and centrifuge at 
full speed for 1 min. 
Perform this step to eliminate any possible carryover of Buffer RPE, or if residual flow-
through remains on the outside of the RNeasy spin column after step 9. 
11. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). Add 30–50 μl 
RNase-free water directly to the spin column membrane. Close the lid gently, and centrifuge 
for 1 min at ≥8000 x g (≥10,000 rpm) to elute the RNA.  
 
 High Capacity RNA-to-cDNA kit 
 
1. Use up to 2 µg of total RNA per 20 µl reaction. 
2. Allow the kit components to thaw on ice  
3. Prepare the RT reaction mix on ice:   
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4. Aliquot 20 μL of RT reaction mix into each well, or tube.  
5. Seal the plates or tubes 
6. Briefly centrifuge the plate or tubes to spin down the contents and to eliminate air bubbles. 
7. Place the plate or tubes on ice until you are ready to load the thermal cycler or Applied 
Biosystems Real-Time PCR system.  
8. Incubate the reaction at 37 °C for 1 hour, stop the reaction by heating to 95 °C for 5 
minutes and cool at 4 °C. 
9. Long-term storage at -15 to -25 °C  
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C. Other results: 
16S rRNA sequencing: 
 
Fig. 3.1: Sequences alignments for P. salmonis 5892 in the BLAST program. 
 
Fig. 3.2: Sequences alignments for P. salmonis 5896 in the BLAST program. 
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Zebrafish embryo immune response to P. salmonis 5692 infection: 
A: Ct-values from Tg(LysC:DsRED2) embryos infected day=1 
 
B: Normalized to PBS values from Tg(LysC:DsRED2) embryos infected day=1 
 
C: Ct-values from Tg(LysC:DsRED2) embryos infected day=6 
 
D: Normalized to PBS values from Tg(LysC:DsRED2) embryos infected day=6 
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E. 
 
 
F. 
 
Fig. 3.3: Immune response of Tg(LysC:DsRED2) embryos infected with P. salmonis 5692 at different time 
points (*= significant).  
A: Ct-values from Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos infected day=1 
 
B: Normalized to PBS values from Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos infected 
day=1  
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C: Ct-values from Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos infected day=6 
 
D: Normalized to PBS values from Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos infected 
day=6 
 
E. 
 
F. 
 
Fig. 3.4: Immune response of Tg(mpeg1:gal4ff):(UAS:nfsB-mCherry) embryos infected with P. salmonis 5692 
at different time points (*= significant).  
 
 
